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Summary 
 
La Boerhaavia diffusa (famiglia delle Nyctaginaceae) è una pianta 
erbacea perenne, nativa dell’India e del Brasile, dove è stata usata, per 
secoli, come pianta medicamentosa dalle popolazioni indigene. Le radici di 
B. diffusa dal punto di vista chimico contengono alcaloidi (punarnavine), 
rotenoidi (boeravinoni A-F), flavonoidi, amminoacidi, lignani 
(liriodendrine) ß-sitosteroli ed acidi tetracosanoici, esacosanoici, stearici ed 
ursolici. Le radici di B. diffusa vengono utilizzate per il trattamento di 
numerose patologie, quali disordini epatici (ittero, epatite, ecc.), gastro-
intestinali (come lassativo), disturbi renali (calcoli, cistiti e nefriti), nel 
trattamento dell’anemia e nella sindrome mestruale. Inoltre recentemente, 
tale droga è anche utilizzata come coadiuvante della terapia antitumorale. 
Nonostante il largo uso in terapia della B. diffusa, allo stato attuale non sono 
presenti in letteratura dati scientifici chiari che (i) dimostrino l’esistenza di 
un’attività farmacologia e (ii) spieghino il meccanismo d’azione. Sulla base 
dell’utilizzo della B. diffusa nella medicina Ayurvedica e della mancanza di 
dati scientifici che spieghino tale utilizzo, lo scopo del nostro studio è stato 
quello di: (i) valutare l’effetto di un estratto metanolico di B. diffusa sulla 
muscolatura liscia intestinale; (ii) studiare la potenziale attività antiossidante 
di tale estratto, (iii) individuare i metaboliti responsabili di tali attività 
farmacologiche, (iv) investigare l’azione di alcuni metaboliti attivi presenti 
nelle radici di B. diffusa (i boeravinoni) sull’attività di una classe di proteine 
note come proteine resistenti al cancro della mammella (Breast cancer 
resistence protein, BCRP), stabilendone una potenziale relazione struttura-
attività, ed infine (v) valutare la potenziale attività citotossica dell’estratto in 
studio e dei metaboliti responsabili delle attività biologiche. Materiali e 
metodi: Studi sulla motilità intestinale. Sono stati condotti studi  
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in vitro sull’ileo isolato di cavia sottoposto all’azione contratturante di 
agenti esogeni (quali acetilcolina, istamina, BaCl2) e della stimolazione 
elettrica (EFS). Attività antiossidante. Sono stati effettuati studi di 
Risonanza di Spin elettronica (ESR) e determinati i livelli di MDA e ROS in 
una linea cellulare di adenocarcinoma umano (Caco-2) sottoposta  a stress 
ossidativo; è stata inoltre valutata la potenziale azione genoprotettiva 
dell’estratto attraverso il saggio della cometa (Comet assay). Effetto sulle 
BCRP. Su una linea embrionale umana di rene (HEK-293) è stato valutato 
l’effetto dei metaboliti attivi dell’ estratto metanolico delle radici di B. 
diffusa sull’accumulo del mitoxantrone. Studi di citotossicità. Sulle Caco-2 
è stato effettuato il test dell’MTT e dell’LDH. Risultati: L’estratto di B. 
diffusa (1-1000 µg/ml) inibiva significativamente ed in maniera 
concentrazione dipendente le contrazioni indotte dagli agonisti esogeni e 
dalla stimolazione elettrica. Tale effetto inibitorio era ridotto in presenza di 
nifedipina ed EDTA, suggerendo un coinvolgimento dei canali del calcio di 
tipo L nel meccanismo d’azione della B. diffusa. L’estratto metanolico di B. 
diffusa (0.1-5 mg/ml) riduceva significativamente ed in maniera 
concentrazione dipendente la formazione di radicali liberi (saggio 
dell’ESR); inoltre, l’estratto in esame cosi come le suesuccesive frazioni 
(30-300 µg/ml) riduceva (i) i livelli di malonildialdeide e di ROS indotti 
nelle Caco-2 dal reattivo di Fenton ed (ii) il danno al DNA indotto 
dall’H2O2. I boeravinoni isolati dall’estratto metanolico di B. diffusa 
inibivano ed in maniera concentrazione dipendente l’escrezione del 
mitoxantrone mediata dalle proteine BCRP (i boeravinoni G ed H sono 
risultati più attivi). Infine, l’estratto di B. diffusa (30-300 µg/ml), non 
induceva effetti citotossici. Attraverso frazionamento guidato dai saggi 
biologici sono stati isolati 15 boeravinoni (dieci noti e 5 nuovi da noi 
denominati boeravinone G, boeravinone H, boeravinone I, boeravinone J e  
II 
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6,10,11-triidrossi-9-metossirotenone). Conclusioni: Nel presente studio è 
stato evidenziato che un estratto metanolico di B. diffusa (i) possiede attività 
spasmolitica sulla muscolatura liscia intestinale. Tale effetto, che potrebbe 
in parte giustificare l’uso tradizionale di tale pianta nel trattamento dei 
disturbi gastrointestinali, sembra dovuto alla presenza di boeravinoni e  
sembra coinvolgere i canali del calcio di tipo L; (ii) presenta un’azione 
antiossidante e genoprotettiva che potrebbe giustificare il suo impiego nei 
disturbi e nelle patologie legate a danni ossidativi. I boeravinoni (G ed H in 
particolare) sono in grado di contrastare il fenomeno di farmacoresistenza 
indotto da antitumorali. 
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Summary  
 
Boerhaavia diffusa (Nyctaginaceae family) is a herbaceous perennial plant, 
native of India and Brazil, where it was used for centuries as a medicinal plant 
by indigenous populations. The root of B. diffusa contains alkaloids 
(punarnavine), rotenoids (boeravinones A-F), flavonoids, amino acids, lignans 
(liriodendrons), ß-sitosterols and tetracosanoic, esacosanoic, stearic and ursolic 
acids. The root of B. diffusa is used for the treatment of many diseases, such as 
liver disorders (jaundice, hepatitis, etc.), gastro-intestinal disorders (as 
laxative), renal disorders (for calculations, cystitis and nephritis), and for the 
treatment of anaemia and of menstrual syndrome. The drug has recently been 
used as an adjuvant in an anticancer therapy. Despite the wide therapeutical 
use of B. diffusa, there are still no scientific data in the literature which clearly 
(i) demonstrate the existence of a pharmacological activity and (ii) explain the 
mechanism of its action. Since B. diffusa is largerly used in Ayurvedic 
medicine and the scientific data that explain such use are deficient, the purpose 
of our study was: (i) to evaluate the effect of the methanolic root extract of B. 
diffusa (BDRME) on the intestinal smooth muscles, (ii) to study the potential 
antioxidant activity of the extract/fractions, (iii) to identify the metabolites 
responsible for such pharmacological activities, (iv) to investigate the action of 
some active metabolites present in BDRME (boeravinones) on the activity of 
the protein type known as the breast cancer resistance protein (BCRP) setting a 
potential relationship structure-activity, and finally, (v) to assess the potential 
cytotoxic activity of the studied extract and its metabolites responsible for the 
given biological activity. Materials and Methods: Studies on Intestinal 
Motility. The in vitro studies were conducted on the isolated ileums of guinea 
pigs subjected to the contractions by exogenous agents (such as ACh, 
histamine, BaCl2) and the electrical stimulation (EFS).  
IV 
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Antioxidant Activity. The Electronic Spin Resonance (ESR) studies were 
conducted to determine the antiradical activity of the BDRME and of its 
fractions. The levels of MDA and ROS were determined in a human 
adenocarcinoma cell line (Caco-2) subjected to the oxidative stress; the 
potential genoprotective action of the extracts was also evaluated by Comet 
assay. Effect on BCRP. The effect of the active metabolites with mitoxantrone 
on the human embryonic kidney line (HEK-293) was assessed. Studies of 
Cytotoxicity. The MTT and LDH tests were conducted on the Caco-2 cells. 
Results: The BDRME (1-1000 µg/ml) significantly and in a concentration 
dependent manner reduced the contractions of isolated guinea pig ileum 
induced by the exogenous agonists and by EFS. This inhibitory effect was 
reduced in the presence of nifedipine and EDTA, suggesting the involvement 
of the calcium channels of the L-type mechanism of B. diffusa action. The 
BDRME (0.1-5 ml/ml) significantly reduced and in a concentration-dependent 
manner the formation of free radicals (ESR assay); moreover, the examined 
extract as well as its fractions (30-300 µg/ml) (i) reduced the levels of 
malonaldehide and ROS induced in Caco-2 by Fenton reaction and (ii) the 
DNA damage induced by H2O2. The isolated boeravinones from the BDRME 
inhibited and in concentration dependent manner the excretion of mitoxantrone 
mediated by BCRP protein (boeravinones G and H were the most active). 
Finally, the BDRME  (30-300 µg/ml) did not induce any cytotoxic effect. 
Through a bio-assay-guided separation, fifteen boeravinones were isolated (ten 
known and five new which we named boeravinone G, boeravinone H, 
boeravinone I, boeravinone J and 6-O-dimethylboeravinone H). Conclusion: 
In the present study it has been shown that BDRME (i) possesses spasmolitic 
activities on intestinal smooth muscles. This effect, which could partially 
justify the traditional use of this plant for the treatment of gastrointestinal 
disorders, seems to be due to the presence of boeravinones and their the 
involvement of extracellular calcium  
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and/or L-type calcium channels and (ii) possesses the antioxidant and 
genoprotective actions that could justify its use in diseases and pathologies 
induces by oxidative damage. The boeravinones (G and H in particular) are 
interesting BCPR inhibitors able to counter the phenomenon of drug resistance 
induced by anticancer drug. 
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1.0 INTRODUCTION 
1.1 Ayurvedic Medicine 
Boerhaavia diffusa is a medicinal plant widely used in the Ayurvedic 
medicine (Lad, 1999).  
Ayurveda is an ancient traditional medical system of health care of the 
Veda civilization, flourishing in India many thousand years ago (Figure 1). 
The term “AYURVEDA” means “Knowledge or Science of Life” (from 
“Ayus” meaning “life” and “Veda” meaning “acquaintance”, “science”) in 
Sanskrit. In fact, Ayurveda focuses on the physical, spiritual and mental 
aspects of an individual. It supports and nourishes all the beneficial values of 
life and, what is more important, this medical practice is not in discord with 
any other medicinal science.  
Ayurveda uses the balancing power of Nature, the power that every plant 
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             Figure 1. Ayurveda system 
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contains, in order to correct the imbalances which are at the root of any 
disease. 
The fundamental nature of the Ayurvedic medical system is based on the 
harmony that exists between the microcosm and the macrocosm. This notion 
was applied to the body by the Ayrvedic physicians as they considered that the 
body was composed of the same elements as the universe was created (earth, 
fire, water, sky and air). According to the teachings of Ayurveda, most of the 
body activities are governed by the three basic body energy control principles 
known as “doshas” (humour) in Sanskrit. Each dosha is made up of one or two 
of the five basic elements and each has a particular relationship to the body 
functions. When the doshas are perfectly balanced, the result is the health with 
the invaluable energy, but when this delicate equilibrium is disturbed (as it 
happens if the body, the mind and the spirit are not in coordination), either 
bodily or mental suffering develops. Each of these three doshas coordinates a 
series of functions as follows: 
 4
• DOSHA VATA - It represents the air and ether principles of the 
movement and the activity. Dosha Vata controls all the activities of the 
nervous system and presides the functions of the respiratory and circular 
systems, the locomotion apparatus and the excretory organs;  
• DOSHA PITTA - It represents the fire and water principles of the 
transformation and the production of energy and heat. Dosha Pitta controls the 
digestive and metabolic functions through the mechanism of the hormonal 
regulation; it also uses bile to direct digestion and hence metabolism into the 
venous system; 
• DOSHA KAPHA - It represents the water and earth principles of the 
cohesion and the structure. Dosha Kapha preserves the integrity of the body 
tissue by controlling the immune system. It governs the equilibrium of the 
fluids at the cellular and tissue levels. This principle relates to mucus, 
lubrication and is the carrier of nutrients into the arterial system promoting the 
increased balance of the body.  
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The balanced interaction of the three doshas concurs the integrated and 
efficient operations of all the body parts and the psychological and physical 
health is experienced; on the contrary, when one or more of the three doshas 
influences are excessive or deficient the balance is disturbed and a disease is 
developed. 
It is apparent that the Ayurvedic medicine, although it was created and 
practiced several thousand years ago, possesses the anatomic and functional 
conceptions of the human body. However, not only has it become actual 
nowadays, but it has turned out to be evolutionary because of its holistic vision 
of the structures and application. 
The Ayurvedic medicine predominantly uses plant drugs, and therefore, it 
can be defined as the phytotherapy comprehended in a very sophisticated way. 
One of the most typical exemplary plants of the Ayurvedic medicine is 
Boerhaavia diffusa Linn (Lad, 1999) (Figure 2). 
1.2  Boerhaavia diffusa  
 6
 
 
 
 
 
       Figure 2. Boerhaavia diffusa 
 
 
 
 7
1.2.1.Botany 
The plant was named in honour of Hermann Boerhaave, a famous Dutch 
physician of the 18th century (Chopra, 1969). 
Boerhaavia diffusa (Spreading Hogweed in English), belonging to the 
family of the Nyctaginaceae, is mainly a diffused perennial herbaceous 
creeping weed of India (known also under its traditional name as Punarnava) 
and of Brazil (known as Erva tostão). Boerhaavia diffusa is up to 1 m long or 
more, having spreading branches. The stem is prostrate, woody or succulent, 
cylindrical, often purplish, hairy, and thickened at its nodes. The leaves are 
simple, thick, fleshy, and hairy, arranged in unequal pairs, green and glabrous 
above and usually white underneath. The shape of the leaves varies considerably 
ovate - oblong, round, or subcordate at the base and smooth above. 
The margins of the leaves are smooth, wavy or undulate. The upper surface of 
the leaves is green, smooth and glabrous, whereas it is pinkish white and hairy 
beneath. The flowers are minute, subcapitate, present 4-10 together in small 
 8
bracteolate umbrellas, mainly red or rose (Figure 3), but the white varieties are 
also known (Figure 4). The achene fruit is detachable, ovate, oblong, 
pubescent, five-ribbed and glandular, anthocarpous and viscid on the ribs 
(Thakur et al., 1989). The seeds germinate before the onset of the monsoon. The 
plant grows profusely in the rainy season and mature seeds are formed in 
October-November. Due to its sticky nature, the plant gets stuck on the clothes 
of humans and on the legs of animals, which helps in its dispersal from one 
place to another. It has a large root system bearing rootlets. The tap root is 
tuberous, cylindrical to narrowly fusiform, conical or tapering, light yellow, brown 
or brownish grey (Figure 5). It is thick, fleshy and very bitter in taste (Capasso et 
al., 2000). 
1.2.2  Ethnobotanical Use 
Various parts of Boerhaavia diffusa are used for the treatment of numerous 
disorders in a different parts of India. In Purulia (West Bengal), the tribes eat this 
plant as a vegetable. Boerhaavia leaves are cooked and eaten in Assam, 
 9
 
 
  
Figure 3. Boerhaavia diffusa flowers 
 
 
   
 
 
 
 
 
 
   
Figura 4.  Boerhaavia diffusa flowers 
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              Figure 5.  Boerhaavia diffusa roots 
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eicosanoids, stearic and ursolic acids (Mishra and Tiwari, 1971), serine, 
liirodendrin (Aftab et al., 1996) carbohydrates, proteins, glycoproteins, etc. 
The most interesting metabolites from the therapeutic point of view are the 
rotenoids (known as boeravinones A - F) (Figure 6) (Misra and Tewari, 1971; 
Jain and Khanna, 1989; Kadota et al., 1989; Lami et al., 1990; 1992). 
1.2.3 Biological Activity 
1.2.3.1 Traditional Medical Use 
The root, leaves, aerial parts or the whole plant of Boerhaavia diffusa have 
been employed for the treatment of various disorders in the Ayurvedic herbal 
medicine (daily used by millions of people in India, Nepal, Sri Lanka and 
indirectly through it being the major influence on Unani, Chinese and Tibetan 
medicines). The root is mainly used to treat gonorrhea, internal inflammation of 
all kinds, dyspepsia, oedema, jaundice, menstrual disorders, anaemia, liver, 
gallbladder and kidney disorders, enlargement of spleen, abdominal pain,  
 12
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abdominal tumours, and cancers (Kirtikar and Basu, 1956), then as a diuretic 
(documented in Indian Pharmacopoeia - Chopra, 1969), digestive aid, laxative 
and a menstrual promoter. The root powder, when mixed with mamira 
(Thalictrum foliolosum), is used to treat eye diseases. It cures corneal ulcers and 
night blindness (Gupta et al., 1962), and helps restore virility in men. People in 
tribal areas use it to hasten childbirth (Shah et al., 1983). The juice of Boerhaavia 
diffusa leaves serves as a lotion in ophthalmia. It is also administered orally as a 
blood purifier and to relieve muscular pain (CSIR, 1988). 
1.2.3.2  Pharmacological and Clinical Properties 
The first pharmacological studies have demonstrated that the root of 
Punarnava exhibits a wide range of properties: anti-inflammatory (Bhalla et al., 
1968, 1971), diuretic (Gaitonde et al., 1974), laxative (Chopra et al. 1956), anti-
urethritis (Nadkarni, 1976), anticonvulsant (Adesina, 1979), antinematodal 
(Vijayalakshmi et al., 1979), antifibrinolytic (Jain and Khanna, 1989), 
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antibacterial (Olukoya et al., 1993), antihepatotoxic (Mishra, 1980; Chandan et 
al., 1991; Rawat et al., 1997), anthelmintic, febrifuge, antileprotic, anti-
asthmatic, antiscabby and antistress activities. An aqueous extract of thinner 
roots of B. diffusa at a dose of 2 mg/kg exhibited the remarkable protection of 
various enzymes such as serum glutanic-oxaloacetic transaminase, serum glutanic-
pyruvic transaminase, and bilirubin in serum against hepatic injury in rats (Rawat 
et al., 1997). Maximum diuretic and anti-inflammatory activities of Punarnava 
have been observed in samples collected during the rainy season. Due to the 
combination of these two activities, Punarnava is regarded therapeutically highly 
efficacious for the treatment of renal inflammatory diseases and common clinical 
problems such as nephritic syndrome, oedema, and ascites developing at the early 
onset of the liver cirrhosis and chronic peritonitis. The root is used to treat other 
renal ailments (calculations and cystitis), seminal weakness and blood pressure 
(Gaitonde et al., 1974) and as a diuretic (Singh et al., 1992; Anand, 1995). It is 
also used in the treatment of stomach ache, anaemia, cough, and cold, and as a 
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diaphoretic, laxative, expectorant and a potent antidote for snake and rat bites 
(Chopra et al., 1956). Punarnava is useful in the treatment of nephritic syndrome 
(Singh and Udupa, 1972), hepatitis, gall bladder abnormalities and urinary 
disorders (Mudgal, 1975; Cruz, 1995). The flowers and seeds are used as a 
contraceptive (Chopra et al., 1956). 
The plant was reported to be efficient for the treatment of the abdominal 
tumours and cancers and was proved to be useful as a haematic and as a growth 
promoter with the children fed with milk fortified with the plant drug. In the form 
of a powder or an aqueous decoction, the plant drug was proved to be beneficial 
in the treatment of nephritic syndrome and compared well with corticosteroids. It 
was also demonstrated that the drug decreased the albumin urea, increased the 
serum protein and lowered serum cholesterol level (Ramabhimaiah et al., 1984). 
Singh and Udupa (1972) reported that the dried root powder showed 
curative efficiency when administered orally for one month to the children or 
adults suffering from the helminth infection. The patients became worm-free 
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within five days of the treatment. The drug, singly or in combination with other 
drugs, was found to be efficient in liver disorders, gastrointestinal disorders, heart 
diseases (hypertension, angina, cardiac failure, etc.), respiratory tract infections, 
leukorrhea, spermatorrhea, etc. The purified glycoprotein from B. diffusa 
exhibited strong antimicrobial activity against RNA bacteriophages (Awasthi and 
Menzel, 1986).  
Chakraborti and Handa (1989) also reported a hepatoprotective activity of 
the aerial parts of B. diffusa. The hepatoprotective activity of the B. diffusa 
root was demonstrated by Rawat (1987) and by Chandan (1991) too. These 
investigators found that the watery extract from the root of B. diffusa 
minimised the toxic effects generated by the CCl4 and the tioacetamide in the 
liver. Further experimental studies also evidenced a beneficial activity of the 
Punarnava root for the treatment of the jaundice (Singh and Pandey, 1980; 
Gopal and Shah, 1985).  
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The treatment with the watery extract from the root of B. diffusa induced 
leucocytosis with predominant neutrophils, associated to the phagocytosis 
ability and it was bactericidal to the neutrophils and the macrophages 
(Mungantiwar et al., 1997).  
The recent study carried out by Pari et al. (2004) demonstrated that the 
leaves of B. diffusa reduced the levels of glucose in the blood increasing the 
insulin release from the β cells of pancreas. The watery extract of B. diffusa 
was proved to possess protective abilities to the rodents suffering from the 
peritonitis induced by Escherichia coli (Hiruma-Lima et al. 2000). 
 It was evidenced that the leaves and root possessed antifibrinolitic and 
anti-inflammatory activities (Hiruma-Lima, 2000). In the recent study, led by 
Mehrotra et al. (2002) was reported that the etanolic extract of B. diffusa 
showed a significant immunosuppressive activity on human cells and on 
murine cells as well.  
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 Toxicological studies conducted on B. diffusa demonstrated the absence 
of teratogenic and mutagenic effects (Singh et al., 1991). 
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2.0 RESEARCH OBJECTIVES 
Boerhaavia diffusa is a widely used plant in Ayurvedic medicine for the 
treatment of  several illnesses such as inflammatory and gastrointestinal ones. 
Despite its extensive use in folk medicine a few phytochemical studies aimed 
at analyzing the effect of this plant have been performed until now.  
Therefore the purpose of the study was: 
1. to estimate the effect of a methanolic root extract of Boerhaavia diffusa on 
the intestinal motility; 
2. to evaluate a potential antioxidant effect of the methanolic root extract of 
Boerhaavia diffusa;  
3. to estimate a genoprotective effect of the methanolic root extract of 
Boerhaavia diffusa; 
4.  to isolate and to identify the active metabolites responsible of the 
pharmacological properties of the Boerhaavia diffusa methanolic root 
extract; 
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5. to perform toxicological study in vitro on the methanolic root extract of 
Boerhaavia diffusa. 
In addition, considering the use of Boerhaavia diffusa in the adjuvant 
treatment of several tumours, another aim of the thesis is: 
6.  to analyse the effect of isolated compounds from the methanolic root 
extract of Boerhaavia diffusa on the Breast Cancer Resistance Protein 
Activity (BSPR). 
 
 
 
 
 
 
 
 
 21
3.0 MATERIALS AND METHODS 
3.1 Plant Material 
 The samples of the root of Boerhaavia diffusa L. (Nyctaginaceae), 
collected in Bangalore (India), were kindly provided by Dr. Carlo Sessa, 
Milan. A voucher specimen (N° 22.02) is deposited in the Carlo Sessa 
Herbarium (Viale Gramsci 212, 20099 Sesto S. Giovanni, Milano, Italy).  The 
rootstocks and root (1,0 kg) were extracted (3 × 3 L) with methanol at room 
temperature for 1 hr. The evaporated pooled extract left a brown substance 
(44.4 g) that was then subjected to the modified Kupchan partition scheme 
which is shown in the adequate place of the study (Kupchan et al., 1973). 
 In order to test the intestinal motility, the methanolic extract of the 
Boerhaavia diffusa root was dissolved in DMSO water (50% v/v). The 
subsequent dilutions were carried out in Krebs solution (see page 29 for 
composition).  
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To test the antioxidant and genoprotective activity and to perform 
toxicological studies, the methanolic root extract of Boerhaavia diffusa was 
dissolved in DMSO water (50% v/v) to obtain a stock solution of 1 mM 
(Hanks’Balance Salt Solution) (MDA assay) or in the cell culture media (MTT 
and Comet assays). 
3.2 Studies on Intestinal Motility 
3.2.1 Substances and Drugs  
 The employed substances to test the intestinal motility were: nifedipine, 
ethylenediaminetetraacetic acid (EDTA), cyclopiazonic acid, acetylcholine 
chloride, histamine and barium chloride (Sigma, Milan, Italy). All chemicals 
and reagents employed in this thesis were of analytical grade.  
 Acetylcholine chloride, barium chloride (BaCl2) and histamine were 
dissolved in distilled water; nifedipine and cyclopiazonic acid were dissolved 
in dimethyl sulfoxide (DMSO) while the EDTA was dissolved in distilled 
water to the constant temperature of 60°C. 
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3.2.2  Bioassay-Guided Isolation of the Active Compounds  
These experiments were done in collaboration with Prof. Ernesto Fattorusso 
and Prof. Orazio Taglialatela-Scafati (Department of Chemistry of Natural 
Products, Faculty of Pharmacy, University of Naples Federico II). 
A small part of the crude methanolic extract (13,4g), obtained from 
Boerhaavia diffusa root, was fractioned following the modified Kupchan 
method (Kupchan et al.,1973). The methanolic extract was dissolved in 
MeOH-H2O (9:1) and then partitioned against n-hexane (3 × 500 ml) to yield 
an apolar extract weighing 1.55 g. Subsequently, the water content of the 
hydromethanolic phase was adjusted to 20% (v/v) and 40 % (v/v) and the 
solutions were partitioned against carbon tetrachloride (CCl4, 3 × 500 ml) and 
chloroform (CHCl3, 3 × 500 ml), respectively, affording the CCl4 (0.56 g) and 
CHCl3 (0.90 g) extracts. Finally, all the MeOH was evaporated from the 
hydromethanolic layer, and the water solution thus obtained was partitioned 
against n-BuOH to yield the butanol (1.32 g) and water  (7.0 g) extracts.  
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The preliminary studies of the intestinal motility showed that the CCl4 and 
the CHCl3 fractions were active and, therefore, they  were further separated. 
The CCl4 was chromatographed by MPLC (Medium Pressure Liquid 
Chromatography) on the silica gel (230-400 mesh) column (750 × 25 mm), 
using a linear gradient system (400 ml for each solvent) from n-hexane to 
EtOAc to MeOH-EtOAc (1:1). The MPLC chromatography is technically 
based on the employment of pumps in order to push the eluent into the 
column. The obtained pressure was between 2 and 4 atmospheres during the 
separate processes. In such a way it was possible to employ the stationary 
phases with a rather fine granulometry, therefore, a good degree of the 
complex solid matrix resolutions. Following the pharmacological profile the 
series of purifications were carried out. All the obtained fractions were 
subjected to biological studies and those more active were further separated by 
HPLC.  
The tetrachloruric fraction (CCl4 fraction) was first separated:  
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the first fraction (n-hexane-EtOAc, 8:2) was purified by HPLC on an 
analytical column (250 × 4.6 mm) using n-hexane-EtOAc (85:15) as an eluent, 
flow rate 1.0 ml/min, affording 2-O-methylabronisoflavone (9, 3.6 mg, tR = 
13.2 min) and coccineone E (8, 7.9 mg, tR = 14.1 min). The second fraction 
(hexane/EtOAc 7:3) was purified by HPLC on analytical column (250 × 4.6 
mm) using hexane/EtOAc 75:25 as an eluent, flow rate 1.0 ml/min, obtaining 
two new compounds, denominate by us, boeravinone G (5, 2.1 mg, tR = 16.5 
min) and boeravinone H (4, 3.8 mg, tR = 14.5 min), and the known compound 
6-O-demethylboeravinone H (3, 1.1 mg, tR = 20.5 min) (Figure 7). The third 
fraction (hexane/EtOAc 6:4) was purified by HPLC on analytical column (250 
× 4.6 mm) using hexane/EtOAc 65:35 as eluent, flow rate 1.0 ml/min, 
obtaining the known compounds boeravinone D (1, 7.5 mg, tR = 15.5 min) and 
boeravinone E (2, 6.3 mg, tR = 19.5 min) (Figure 7). 
The fourth fraction (n-hexane-EtOAc, 1:1) was purified by HPLC on an 
analytical column (250 × 4.6 mm) using n-hexane-EtOAc (55:45) as eluent, 
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Figure 7. Rotenoids isolated from the methanolic root extract of Boerhaavia diffusa and 
tested on intestinal motility, antioxidant, genoprotective and cytotoxic activities. 
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flow 1.0 ml/min, affording the known compound 7 (4,11,12a-trihydroxy-9-
methoxyrotenone, 1.8 mg, tR = 12.5 min). The fifth fraction (n-hexane-EtOAc, 
4:6) was purified by HPLC on an analytical column (250 × 4.6 mm) using n-
hexane-EtOAc (4:6) as eluent, flow rate 0.8 ml/min, yielding boeravinone C 
(6, 5.5 mg, tR = 12.9 min). Finally, the sixth fraction (n-hexane-EtOAc, 3:7) 
was purified by HPLC on analytical column (250 × 4.6 mm) using n-hexane-
EtOAc (35:65) as an eluent, flow rate 0.8 ml/min, affording another new 
compound - 6,10,11-trihydroxy-9-methoxyrotenone (12, 1.5 mg, tR = 8.8 min). 
 The CHCl3 extract was chromatographed by MPLC on a silica gel (230-
400 mesh) column (750 × 25 mm), using a linear gradient system (400 ml for 
each solvent) from n-hexane-EtOAc (7:3) to EtOAc to EtOAc-MeOH (1:1). 
The fraction eluated with EtOAc-n-hexane (7:3) was further purified by HPLC 
(EtOAc-n-hexane, 6:4, flow rate 0.8 ml/min) yielding boeravinone F (10, 2.2 
mg, tR = 7.9 min) and coccineone B (11, 2.1 mg, tR = 9.0 min) in the pure state 
(Figure 7). 
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Boeravinone G (5): pale yellow amorphous solid; yield: 2.1 mg, purity: 
98% (by HPLC, RI detection, and NMR); [α]D25 0° (c 0.01 in CHCl3); IR 
(KBr): νmax 3250, 1648, 1618 cm-1; UV (CH3CN): λmax 343, 300, 279 nm (logε: 
3.70,4.30, and 4.50, respectively). 1H (500 MHz) and 13C (125 MHz) NMR 
spectra (CDCl3): see Appendix. ESIMS (negative ions): m/z 341 [M-H]-. EIMS 
(70 eV): m/z 342 [M]+ (40), 311 [M-OCH3]+ (100). HREIMS: found m/z 
342.0731 (calcd. for C18H14O7, m/z 342.0740). 
Boeravinone H (4): pale yellow amorphous solid; yield: 3.8 mg, purity: 
98% (by HPLC, RI detection, and NMR); [α]D25 0° (c 0.01 in CHCl3); IR 
(KBr): νmax 3248, 1648, 1618 cm-1; UV (CH3CN): λmax 345, 302, 279 nm (logε: 
3.70,4.30, and 4.50, respectively). 1H (500 MHz) and 13C (125 MHz) NMR 
spectra (CDCl3): see Appendix. ESIMS (negative ions): m/z 355 [M-H]-. EIMS 
(70 eV): m/z 356 [M]+ (40), 325 [M-OCH3]+ (100). HREIMS: found m/z 
356.0908 (calcd. for C19H16O7, m/z 356.0896). 
6,10,11-Trihydroxy-9-methoxyrotenone (12): pale yellow amorphous 
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solid; purity 98% (by HPLC and NMR); [α]D25 0 (c 0.01, MeOH); UV 
(CH3OH) λmax 343, 281 nm (logε 3.70 and 4.50, respectively); UV (CH3OH + 
AlCl3) λmax 378, 284 nm; UV (CH3OH + AlCl3/HCl) λmax 381, 285 nm; UV 
(CH3OH + NaOAc/H3BO3) λmax 352, 285 nm; IR (KBr) νmax 3270, 1650, 1616 
cm-1; 1H NMR (500 MHz, CD3OD): see Appendix. ESIMS (negative-ion) m/z 
327 [M-H]-; EIMS (70 eV): m/z 328 [M]+ (30), 311 [M-OH]+ (100); HREIMS 
found m/z 328.0576 (calcd for C17H12O7, m/z 328.0583). 
The structure of these molecules was identified on the basis of the 
comparison of their spectral data (NMR) with those reported in the literature. 
3.2.3 Animals 
Guinea pigs (New Zealand, weighing 250-400 g), supplied by Harlan Italy, 
Corezzana, MI, Italy, were used after 1 week of acclimation (light-dark cycles, 
for 12 hrs, temperature 23 ± 2°C; humidity 60%). The rodents had free access 
to water and food (supplied by the Eat Mucedola company, Settimo Milanese, 
Italy). All experiments on the animals complied with the Italian D.L. no. 116 
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of 27 January 1992 and the associated guidelines in the European Community 
Council Directive of 24 November 1986 (86/609/ECC). 
3.2.4 Guinea Pig Ileum Isolation  
Guinea-pigs were killed by asphyxiation with CO2 and the segments (2–
3 cm) of the terminal ileum were removed, flushed of luminal contents and 
placed in the Krebs solution (composition in mM: NaCl 119, KCl 4.75, 
KH2PO4 1.2, NaHCO3 25, MgSO4 1.5, CaCl2 2.5, and glucose 11). The 
isolated ileum parts were cut perpendicularly along the longitudinal muscles to 
obtain segments of 1 cm length. The ileum segments were suspended in a bath 
(37°C) containing the Krebs solution which was aerated (95% O2 : 5% CO2). 
The tissues were connected to a isotonic transducer (load 0.5 g) connected to a 
PowerLab data-acquisition system (Ugo Basile, Comerio, Italy).  
3.2.5 Contractions Induction 
 At the beginning of each experiment, the ileum segments was stimulated 
with acetylcholine (10-3 M) in order to obtain a maximal contraction (100% 
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contraction). After a minimal one-hour of the equilibration period, the tissues 
were subjected to (i) the electrical field stimulation (EFS, 10 Hz for 0.3 s, 
100 mA, 0.5 ms pulse duration using a multiplexing pulse booster by Ugo 
Basile, Milan, Italy) via a pair of platinum electrodes (situated at the distance 
of 1.5 cm) placed around the intestine or (ii) stimulated with exogenous 
spasmogens, namely acetylcholine (10-6 M), BaCl2 (10-3 M) and histamine (10-6 
M). The concentrations of the agonists gave a contractile response which was 
similar in amplitude to that of EFS. Acetylcholine, BaCl2 and histamine, added 
to the bath, were left in contact with the tissue for 30 sec. After recording the 
contractions, the ileum was washed with the Krebs solution in order to remove 
the effects of the exogenous spasmogens. After at least three stable control 
contractions, the responses were repeated in the presence of increasing (non-
cumulative) concentrations of B. diffusa methanolic root extract (1-1000 
µg/ml) added 20 min before the contacting stimulus (after washing the tissue). 
The preliminary experiments showed that a 20 min contract time was 
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sufficient for the B. diffusa methanolic root extract to achieve the maximal 
inhibitory effect. 
The conditions of EFS were selected so that the contractile responses were 
similar in amplitude to those of acetylcholine, histamine and BaCl2. The stable 
and reproducible contractions for a period of 4 hrs were obtained, with 
stimulations every 20 min. After the stable control contractions evoked by EFS 
of the cholinergic nerves had been registered, the responses were observed in 
the presence of the increased cumulative concentrations of B. diffusa 
methanolic root extract (1-1000 µg/ml). The contact time for each 
concentration was 20 min.  
In the preliminary experiments, the effect of tetrodotoxin (TTX; 3 ×10-7 M, 
contact time: 20 min) was evaluated on both exogenous spasmogens - and 
electrical - induced contractions. The electrical stimulation of the guinea pig 
ileum gave a contractile response that was abolished by TTX (3 × 10-7 M) 
(data not shown). By contrast, the contractions induced by acetylcholine, 
 33
histamine, and BaCl2 were not modified by TTX (3 × 10-7 M) (data not 
shown).  
In some experiments, the effect of B. diffusa methanolic root extract on 
acetylcholine-induced contractions was performed in the presence of 
nifedipine (10-6 M -a blocker of L-type Ca2+ channels), cyclopiazonic acid (10-
5 M - a potent and specific inhibitor of the sarcoplasmic reticulum Ca2+-
ATPase in smooth muscle), and ethylenediaminetetraacetic acid (EDTA, 10-3 
M - a calcium chelator) (contact time: 20 min). The concentrations of 
nifedipine, cyclopiazonic acid and EDTA were selected on the basis of 
previous studies (Uyama et al., 1992; Izzo et al., 1999; Aronsson and 
Holmgren, 2000; Lis-Balchin and Hart, 2002). When given alone (i.e., in the 
absence of B. diffusa methanolic root extract), nifedipine (10-6 M), EDTA (10-3 
M) and cyclopiazonic acid (10-5 M) significantly (p <0.01) reduced (% 
reduction: nifedipine: 47.3 ± 2.9, EDTA: 49.7 ± 5.2, cyclopiazonic acid: 52.3 ± 
5.8, n = 8 for each drug) the contractions induced by acetylcholine. 
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3.3 Antioxidant Activity 
3.3.1 Substances and Drugs  
The used substances to test antioxidant activity were: sodium chloride, 
dimethyl sulfoxide, sodium hydroxide, malondialdehyde, trypsin, trypan blue, 
methanol, hydrogen peroxide, ferrous sulphate, Tris, Triton-X, 5,5-dimethyl-1-
pyrroline N-oxide (DMPO), sucrase, oxidase/peroxidase, O-dianisidine, 2’,7’- 
dichlorfluorescein-diacetate (H2DCF-DA) and 1,1,3,3-tetramethoxypropane 
which were purchased from Sigma (Milan, Italy). All the reagents for the 
cellular cultures were supplied by the Microtech Research Products (Naples, 
Italy). EDTA, sodium chloride, ethidium, sodium hydroxide and Tris were 
dissolved in distilled water. The ferrous sulphate was dissolved in HBBS 
(Hanks' Balanced-Salt Solution).  
3.3.2 Bioassay-Guided Isolation of the Active Compounds 
 These experiments were done in collaboration with Prof. Ernesto 
Fattorusso and Prof. Orazio Taglialatela-Scafati (Department of Chemistry 
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of Natural Products, Faculty of Pharmacy, University of Naples Federico II). 
A small part of the crude methanolic extract (13,4g), obtained from B. 
diffusa root, was fractioned following the modified Kupchan method (Kupchan 
et al.,1973), as was explained on page 23. The most antioxidant fraction (CCl4) 
was chromatographed by MPLC on silica gel (230-400 mesh) column (750 × 
25 mm), using a linear gradient system (400 ml for each solvent) from n-
hexane to EtOAc to MeOH-EtOAc (1:1). The obtained fractions were pooled 
on the basis of their TLC behavior to afford 13 fraction called BOE-1 to BOE-
13. All these fractions were subjected to the ESR assay and the most active, 
BOE-4, BOE-6, BOE-8 and BOE-9 were further separated by HPLC. Both 
BOE-4 (n-hexane-EtOAc, 8:2) and BOE-6 (n-hexane-EtOAc, 7:3) fractions 
were purified by HPLC on an analytical column (250 × 46 mm) using n-
hexane-EtOAc 75:25 as eluent (flow rate 1.0 ml/min) and afforded as the main 
component boeravinone D (1, Figure 11, 6.4 mg). The BOE-8 fraction (eluated 
with hexane/EtOAc 6:4) was purified by HPLC on an analytical column using 
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hexane/EtOAc 7:3 as an eluent, flow rate 1.0 ml/min, obtaining boeravinone G 
(5, Figure 11, 7.5 mg). Finally, the BOE-9 fraction (eluated with 
hexane/EtOAc 1:1) was purified by HPLC on an analytical column using 
hexane/EtOAc 6:4 as an eluent, flow rate 1.0 ml/min, obtaining boeravinone H 
(4, Figure 11, 5.2 mg). The structure of these molecules was identified on the 
basis of the comparison of their spectral data with those reported in the 
literature.  
3.3.3 Cell Culture 
Human colon adenocarcinoma cells (Caco-2 cells) were used for the 
experiments. Caco-2 cells were cultured in Roux flasks as monolayers in 
DMEM (Dulbecco's Modified Eagle Medium) containing 10% FBS (foetal 
bovine serum), 1% non-essential amino acids and 100 U/l 
penicillin/streptomycin, 1% L-glutamine 2mM and 2.5% HEPES (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid). The cells were cultured for 7 
days (~ 70% confluence) at 37°C in the humidified 5% CO2 and 95% air and 
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the culture medium was replaced every 2 days. After washing in PBS 
(phosphate buffered saline), the cells were trypsinized with 0.25 % trypsin-
EDTA at 37°C for 5 min, centrifuged at 1200 rpm/3 min and re-suspended in 
the appropriate medium. The viability of the cells was estimated by trypan 
blue staining. The Caco-2 cells were purchased from the American Type 
Cultures Collection (ATCC, Milan, Italy). 
3.3.4 Electronic Spin Resonance Spectrometer (ESR) 
 The effect of the methanolic root extract of B. diffusa and of its fractions 
were tested on the formation and the transformation of the hydroxyl radicals 
obtained by the Fenton reaction [0.2 ml of H2O2 (10 mM), 0.2 ml of FeCl2 x 4 
H2O (10 mM) and 0.2 ml of 5,5-dimethyl-1-pyrroline N-oxide (DMPO, 0,3 M) 
used as a spin trap (blank)]. The hydroxyl radical production was detected by 
the ESR spectrometer Bruker 3000E (Rheinstetten, Germany) with the 
following settings: field modulation 100 kHz, modulation amplitude 0.512 G, 
receiver gain 2 × 105, time constant 81.92 ms, conversion time 163.84 ms, 
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center field 3440.00 G, sweep width 100.00 G, x-band frequency 9.64 GHz, 
power 20 mW, temperature 23°C (Čanadanović-Brunet et al., 2005). The ESR 
spectrometer is made of a source of electromagnetic radiations (a cavity 
located between the poles of an electromagnet where the sample under the 
investigation is put), an electromagnet (where the generation of the oscillating 
magnetic field is produced) and an apparatus capable to record the quantity of 
radiations absorbed from the samples (Figures 8a and 8b). 
 The influence of the methanolic root extract of B. diffusa and its 
fractions (constituents) on the formation and transformation of hydroxyl 
radicals were investigated by adding the B. diffusa methanolic root extract to 
the Fenton reaction system in the range of the concentrations 0.10-5 mg/ml 
and 0.01-1 mg/ml for the B. diffusa methanolic root extract fractions, 
respectively.  
The methanolic root extract of B. diffusa of the 0.1-5 mg/ml concentrations 
was introduced in the cavity of the ESR spectrometer in which the Fenton 
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Figure 8: ESR Spectrometer (a) and ESR scheme (b) 
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reagent had previously been inserted. The ESR spectra were recorded after 5 
min of the beginning of the reaction under the following conditions: 100 KHz 
intensity, amplitude 0,512 G, constant time 81.92 ms, time of conversion 
163.84 ms, curve amplitude 100,00 G, frequency band 9.64 GHz, power 20 
mW, temperature 23°C (Cetkovic et al., 2004). The antiradical activity (AA) 
of the extracts was expressed as a percentage of the height reduction of the 
peaks height under the given formula: 
AA = 100x [(I h0-hx)/h0] 
Where: 
ho= height of the peak before adding the extract (the control)  
hx= height of the peak after adding one of the extracts (investigated probe) 
3.3.5  Sucrase - Isomaltase Activity Determination 
Sucrase-isomaltase is the most studied brush border enzyme and it is a good 
 differentiation marker. It is found on the luminal surface of the Caco-2 cells 
and in small intestinal cells. The activity of sucrase-isomaltase is low during 
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the proliferation phase and increases once the confluence is reached. The 
sucrase- isomaltase activity was detected using Dahlqvist method (1970). The 
Caco-2 cells were seeded in 6-well plates at the density of 4.0 x 105 cells/well 
in DMEM supplemented with 10% FBS at 37°C for 3, 5, 7, 10, 12 and 14 
days. After washing in PBS, the cells were collected with a lysis buffer (50mM 
Tris-HCl pH=7.4, 0.25 % sodium deoxicolate, 150 mM NaCl, 1 mM EGTA, 1 
mM NaF, 1% NP-40, 1 mM PMSF, 1 mM Na3VO4 and a mixture of protease 
inhibitors) (Roche Diagnostics, Mannheim, Germany). The cells were 
subsequently centrifuged at 13000 rpm for 10 min at 4°C and an aliquot of the 
extract was used for the proteic detection with the Bradford method (Bio-Rad, 
CA). An aliquot of proteic extract was incubated with a sucrase solution for 1 
hr at 37°C. Then the samples were incubated with a glucose 
oxidase/peroxidase and O-dianisidine to allow sucrase - isomaltase to convert 
the glucose and fructose in orange-brown chromophor, which was evaluated 
spectrophotometrically at the wavelength (λ) of 430 nm.  
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3.3.6  TBARS Assay 
Malondialdehyde (MDA) is a product of the lipid peroxidation. It is a 
powerful toxic member which causes the “cross-linkage” of proteins and 
enzymes, altering their biological functions. The effect of the B. diffusa 
methanolic root extract (30-300 µg/ml) on lipid peroxidation was assessed by 
measuring the cytosolic levels of thiobarbituric acid reactive substances 
(TBARS) according to Ohkawa et al. (1979). The Caco-2 cells were seeded in 
the 6-well plates at the density of 3.0×106 per well and led to the 
differentiation (evaluated with succrase-isolmaltase assay). The differentiated 
cells were treated with the B. diffusa methanolic root extract (30-300 µg/ml) or 
boeravinone G (0.0001-0.001 µg/ml) for 24 hrs and then washed with PBS and 
incubated with the Fenton reagent (H2O2/Fe2+ 1 mM) for 3 hrs at 37°C. After 
the incubation, the cells were washed and scraped in PBS. The cells were lysed 
by six cycles of freezing and thawing in PBS and then centrifuged at 13000 
rpm for 10 min at 4°C. The 300 µl of 10% (w/v) trichloroacetic acid (TCA) 
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was added to 150 µl of cellular lysate and, after centrifugation at 13000 rpm 
for 10 min, 0.67% (w/v) of thiobarbituric acid was added to the supernatant 
and the mixture was heated at 80°C for 30 min. After cooling, the 
malondialdehyde (MDA) formation was determined spectrophotometrically 
with the wavelength (λ) of 532 nm using a multiwell plate reader (Beckman 
DU62). The quantification of TBARS was determined by comparing its 
absorption curve to the standard curve of the malondialdehyde (MDA) 
equivalents generated by the acid catalyzed hydrolysis of 1,1,3,3-
tetramethoxypropane. The results were presented as µmol of MDA/mg of the 
cell protein determined by the Bradford assay (Bio-Rad). 
3.3.7 Intracellular ROS Measurement 
The generation processes of the intracellular reactive oxygen species (ROS) 
can be monitored using the fluorescence probe 2’,7’-dichlorfluorescein-
diacetate (H2DCF-DA) (Yokomizo et al., 2006). The H2DCF-DA is a non-
fluorescent permeant molecule that diffuses passively into cells, where the 
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acetate is cleaved by intracellular esterases to the non-fluorescent H2DCF 
which thereby traps it within the cell. In the presence of intracellular ROS, 
H2DCF is rapidly oxidized to the highly fluorescent 2′,7′- dichlorofluorescein 
(DCF). Therefore the DCF fluorescence intensity is paralleled to the amount of 
ROS formed intracellularly. For the experiments, the cells were plated in a 96 
multiwell black plate (Corning, USA) at the density of 1×104 cells per well and 
led to the differentiation (evaluated with sucrase-isomaltase assay). The 
confluent Caco-2 cell monolayers were incubated for 24 hrs at 37°C with the 
B. diffusa methanolic root extract (30-300 µg/ml) or boerhavinone G (0.0001-
0.001 µg/ml). The cells, were then, rinsed and incubated for 30 min with 200 
µl of 100 µM DCFH-DA in HBSS containing 1% FBS. Finally, the cells were 
rinsed and incubated with the Fenton reagent (H2O2/Fe2+ 2 mM) for 3 hrs at 
37°C. The DCF fluorescence intensity was detected using a fluorescent 
microplate reader (Perkin-Elmer Instruments) at the excitation wavelength (λ) 
of 485 nm and the emission wavelength (λ) of 538 nm. 
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3.4  Genoprotective Assay 
3.4.1  Substances and Drugs 
The substances used to test genoprotective activity were: agarose, sodium 
chloride, sodium hydroxide, ethidium bromide, trypsin, trypan blue, hydrogen 
peroxide, ferrous sulphate, Tris and Triton-X which were purchased from 
Sigma (Milan, Italy). All the reagents for the cellular cultures were supplied by 
the Microtech Research Products (Naples, Italy). EDTA, sodium chloride, 
sodium hydroxide and Tris were dissolved in distilled water. Agarose and 
ethidium bromide were dissolved in PBS.  
3.4.2 Bioassay-Guided Isolation of the Active Compounds  
The isolation procedure is described on page 34. 
3.4.3 Comet Assay 
The presence of the DNA fragmentation was examined by the single cell 
gel electrophoresis (Comet assay), as described by Gill et al. (2005). The 
Caco-2 cells were seeded in the 25 cm2 flasks at the density of the 4x105 cells 
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and incubated with the B. diffusa methanolic root extract (30-300 µg/ml) at 
37°C for 24 hrs. After the incubation with and without 75µM H2O2 challenge 
for 5 min on ice, the Caco-2 cells (1 × 105 cells) were centrifuged at 1250 rpm 
for 5 min. The supernatant was discarded and the pellet was mixed with 85 µl 
of 0.85% low melting point agarose (LMA) in PBS. The cells were added to 
the previously prepared gels of 1% normal agarose (NMA). The gels on the 
frosted slides were maintained in the lysis solution (2.5 M NaCl, 100 mM 
Na2EDTA, 10 mM Tris and 1%Triton X-100, pH 10) at 4°C for 1 hr, and, 
then, electrophoresed in a appropriate buffer (300 mM NaOH, 1 mM 
Na2EDTA, pH>12) at 26 V, 300 mA for 20 min. After running, the gels were 
neutralized in 0.4 M Tris–HCl, pH 7.5 (3 x 5 min washes) and stained with 
20 µl of ethidium bromide (2 µg/ml) before scoring. The images were analyzed 
using a fluorescence microscope (Nikon) interfaced with the computer. The 
Komet 5.0 image analysis software (Kinetic Imaging) allowed to analyze and 
quantify the DNA damage by measuring the tail length. For each slide, 100 
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cells were scored. The positive (H2O2; 75 µmol/l) and negative (PBS) controls 
were included for all the experiments. The mean percentage of the DNA tail 
was calculated from 100 cells per gel (each sample in triplicate) and the mean 
of each independent experiment (n = 3) was used in the statistical analysis.  
3.5 BCRP Mediated Inhibition Assay 
3.5.1 Substances and Drugs 
Dimethyl sulfoxide (0.5% final solution), mitoxantrone (5 µM), elaclidar 
(µM) and PBS were used. 
3.5.2 Bioassay-Guided Isolation of the Active Compounds 
These experiments were done in collaboration with Prof. Ernesto Fattorusso 
and Prof. Orazio Taglialatela-Scafati (Department of Chemistry of Natural 
Products, Faculty of Pharmacy, University of Naples Federico II). 
A small part of the crude methanolic extract (13,4g), obtained from B. diffusa 
root, was fractioned following the modified Kupchan method (Kupchan et 
al.,1973), as was explain on page 22. For this part of the experiments the CCl4 
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and CHCl3 fractions were combined and then chromatographed by MPLC on a 
silica gel (230-400 mesh) column (750 × 25 mm), using a linear gradient 
system (400 ml for each solvent) from n-hexane to EtOAc to MeOH-EtOAc 
(1:1). All obtained fractions were subjected to the preliminary spectroscopic 
investigation and those apparently containing rotenoids were further separated 
by HPLC. The first fraction (n-hexane-EtOAc, 8:2) was purified by HPLC on 
an analytical column (250 × 4.6 mm) using n-hexane-EtOAc 85:15 as an 
eluent, flow rate 1.0 ml/min, affording coccineone E (8, 7.9 mg) (Figure 9). 
The second fraction eluated with hexane/EtOAc 7:3 was purified by HPLC on 
an analytical column using hexane/EtOAc 75:25 as an eluent, flow rate 1.0 
ml/min, obtaining boeravinone G (5, 8.8 mg), boeravinone H (4, 6.4 mg), 6-O-
demethylboeravinone H (3, 2.4 mg), boeravinone A (13, 12.3), and 
boeravinone B (14, 6.2 mg). The third fraction eluated with hexane/EtOAc 6:4 
was purified by HPLC on an analytical column using hexane/EtOAc 65:35 as 
an eluent, flow rate 1.0 ml/min, obtaining boeravinone E (2, 8.4 mg). The  
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Figure 9. Rotenoids isolated from the methanolic root extract of Boerhaavia diffusa and 
tested on BCPR activity 
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fourth fraction eluated with n-hexane-EtOAc, 1:1, was purified by HPLC on 
an analytical column (250 ×  46 mm) using n-hexane-EtOAc 55:45 as an 
eluent, flow rate 1.0 ml/min, affording the new compounds boeravinone I (15, 
1.3 mg) and boeravinone J (16, 1.1 mg) (Figure 9). The fraction eluated with 
n-hexane-EtOAc 4:6 was purified by HPLC on an analytical column using n-
hexane-EtOAc 4:6 as an eluent, flow rate 0.8 ml/ min, yielding boeravinone C 
(6, 5.1 mg). Finally, the fraction eluated with EtOAc-n-hexane 7:3 was further 
purified by HPLC (EtOAcn - hexane, 6:4, flow rate 0.8 ml/min,) yielding 
coccineone B (11, 3.9 mg) (Figure 9). 
Boeravinone I (15): it is pale yellow amorphous solid; [α]25D 0 (c0.01, 
MeOH); UV (CH3OH): λmax (log є) 330 nm (3.85), 274 nm (4.50); UV 
(CH3OH + AlCl3): λmax 363, 280 nm; UV (CH3OH + AlCl3/HCl): λmax 371, 
283 nm; UV (CH3OH + NaOAc/H3BO3): λmax 331, 274 nm; 1H NMR (500 
MHz, CD3OD) and 13C NMR (125 MHz, CD3OD): see Appendix. ESIMS 
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341.0666 (calcd for C18H13O7, m/z 341.0661). (negative-ion) m/z 341 [M - H]-; 
HRFABMS (negative ions): found m/z 
Boeravinone J (16): it is yellow amorphous solid; UV (CH3OH): λmax (log 
є ) 340 nm (3.40), 276 nm (4.40); UV (CH3OH + AlCl3): λmax 374, 283 nm; 
UV (CH3OH + AlCl3/HCl): λmax 382, 289 nm; UV (CH3OH + 
NaOAc/H3BO3): λmax 340, 276 nm; 1H NMR (500 MHz, CD3OD) and 13C 
NMR (125 MHz, CD3OD): see Appendix. ESIMS (negative-ion) m/z 297 [M - 
H]-; HRFABMS (negative ions) found m/z 297.0405 (calcd for C16H9O6, m/z 
297.0399). 
3.5.3 Cell Culture  
Human embrional kidney cells (HEK-293) transfected by wild-type (R482) 
BCPR were used. 
3.5.4 BCPR Inhibition 
The inhibitory protein activity of boeravinones was assayed by flow 
cytometry (Ahmed-Belkacem et al. 2005). The HEK-293 human cells were  
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transfected by wild-type (R482) BCRP and were exposed to 5 µM 
mitoxantrone for 30 min at 37 °C, either in the absence or the presence of the 
inhibitor added as a dimethyl sulfoxide solution (0.5% final concentration), 
washed in PBS, and further incubated for 60 min with the same inhibitor 
concentration in the mitoxantrone-free medium. The residual intracellular drug 
fluorescence was monitored with a FACscan flow cytometer (Becton 
Dickinson, Moutain View, CA). The maximal fluorescence (100%) was the 
difference between the mean fluorescence of the control cells (transfected with 
empty vector) and BCRP-transfected ones incubated with the substrate but 
without the inhibitor. The same maximal fluorescence with the latter cells was 
obtained in the presence of 5 µM ELACRIDAR, taken as a reference inhibitor 
of BCRP-mediated drug efflux. The addition of boeravinones did not 
significantly modify the fluorescence of the control cells and the cells without 
the drug were taken as an auto fluorescence control. 
3.6. Toxicological Studies 
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3.6.1 Substances and Drugs 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
and the LDH leakage commercial kit were purchased from Sigma (Milan, 
Italy). All the reagents for the cellular cultures were supplied by the Microtech 
Research Products (Naples, Italy). The 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide was dissolved in sterile PBS.  
3.6.2 Bioassay-Guided Isolation of the Active Compounds 
The isolation procedure is described on page 34. 
3.6.3  MTT Assay 
The cellular vitality was assessed by the MTT [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide] assay, as described by Mosmann (1983), 
which is based on the ability of mitochondrial dehydrogenases to cut the 
tetrazolic ring of the MTT and transform the MTT from a yellow water soluble 
substance into the dark purple insoluble crystals of formazan. The Caco-2 cells 
were seeded in 96 multiwell plates at a density of 1x104 cells/well to the final 
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volume of 200 µl DMEM. After the incubation of the cells (24 hrs) with the B. 
diffusa methanolic root extract (30-300 µg/ml) and boeravinone G (0.0001-
0.001 µg/ml), the cell culture was then incubated with the MTT solution (0.25 
mg/ml) for 1 hr at 37 °C. The supernatant was removed and the formed 
formazan crystals were dissolved in DMSO (100 µl/well) at room temperature 
for 10 min. The absorbance was read at a wavelength (λ) of 490 nm in a 
multiwell plate reader (Bio-Rad, Model 550).  
3.6.4 Lactate Dehydrogenase (LDH) Leakage Assay 
Lactate dehydrogenase, also called lactic dehydrogenase (LDH) is an 
enzyme responsible for converting lactic acid into pyruvic acid, an essential 
step in producing cellular energy. The LDH leakage assay indicates the cell 
viability and integrity after the damaging exposure. It is a fluorometric assay 
that measures the release of LDH from the cells with a damaged membrane by 
the conversion of resazurin into resorufin (Shimma et al.,2003). The Caco-2 
cells were seeded in 6-well plates at the density of 3.0 x106 per well and led to 
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the differentiation. The differentiated cells were treated with the methanolic 
root extract of B. diffusa (30-300 µg/ml) and boeravinone G (0.0001-0.001 
µg/ml) for 24 hrs. An aliquot of the medium was removed from the culture 
plates and then analyzed for LDH leakage into the culture media by using a 
commercial kit. The total LDH activity was determined after the cells were 
scraped and thoroughly disrupted by Ultra Turax for 30 seconds. The 
percentage of LDH leakage was then calculated to determine the membrane 
integrity. The LDH leakage was expressed as a percentage of the total activity: 
(activity in the medium)/(activity in the medium + activity of the cells) x 100.  
3.6.5 Genotoxicity Assay (Comet Assay)  
In this assay the presence of the DNA fragmentation was examined by the 
single cell gel electrophoresis (Comet assay), as described by Gill et al. (2005). 
The Caco-2 cells were seeded in the 25 cm2 flasks at the density of the 4x105 
cells and incubated with the B. diffusa methanolic root extract (30-300 µg/ml) 
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at 37°C for 24 hrs. After the incubation, the potential B. diffusa-induced DNA 
damage was investigated as reported on the page 44. 
3.7 Statistical Analysis 
The results are expressed as the arithmetic mean  ± S.E. mean [or 95% 
confidence limits (C.L.) of the IC50 values]. The comparisons between the two 
sets of data were made by Student’s t-test for paired data. When the multiple 
comparisons against a single control were made, ANOVA was used, followed 
by the Bonferroni’s multiple comparisons test. Analysis of variance (two way) 
was used to compare different cumulative concentration-effect curves. For the 
genotoxicity test (Comet assay) the data were statistically analyzed in a 
quantitative way, using a software of image analysis in a position to calculate 
parameters like “tail length” and “tail moment”. The average percentage of the 
DNA tail was calculated on 100 cells for the triplet gel and the average of it is 
used for the analysis statistics. The arithmetic mean IC50 values and 95% C.L. 
were calculated by analyzing the regression lines according to Tallarida and 
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Murray (1996). Emax values were calculated using the Graph Pad Instat 
program version 4.01. A p-value of less than 0.05 was considered significant.  
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4.0 RESULTS 
4.1 Spasmolytic Activity  
The methanolic root extract of B. diffusa (1-1000 µg/ml) significantly, and 
in a concentration-dependent manner, inhibited the electrical field stimulation 
(EFS) -, acetylcholine-, histamine-, and BaCl2- induced contractions of the 
isolated guinea pig ileum (Figure 10). The inhibitory effect of the methanolic 
root extract of B. diffusa on EFS-, acetylcholine-, histamine-, and BaCl2- 
induced contractions was similar; in fact, the curves were overlapping and the 
arithmetic IC50 mean values (95% C.L.) for EFS, acetylcholine, histamine and 
BaCl2 were 182 (138-240) µg/ml, 160 (121-212) µg/ml, 168 (132-213) µg/ml, 
and 158 (117-215) µg/ml, respectively.  
The inhibition produced by the methanolic root extract of B. diffusa was 
reversible, since at the end of the experiment (after washing the tissues), the 
spasmogens produced the contractions with an amplitude similar to the one 
obtained at the beginning of the experiment (before the treatment with the 
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Figure 10. Effect of the methanolic root extract of Boerhaavia diffusa (1-
1000 µg/ml) on contractions induced by acetylcholine (10-6 M), histamine 
(10-6 M), barium chloride (10-4 M), and electrical field stimulation (EFS, 
2.5 Hz for 2 s, 400 mA, 1 ms pulse duration) on isolated guinea pig ileum. 
Each point represents the mean ± SEM of 6-8 experiments. 
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B. diffusa methanolic root extract). 
Since the B. diffusa methanolic root extract inhibited the contractions 
induced by three different spasmogens, a common site of an action on the 
smooth muscle was hypothesized, for example, the involvement of cytosolic 
Ca2+, which is known to play an important role in the contractile processes of 
smooth muscle (Makhlouf, 1994). Therefore, the action of calcium 
antagonists/blockers on the spasmolytic effect of the B. diffusa methanolic root 
extract was evaluated. The inhibitory response of B. diffusa on the ACh-
induced contractions was significantly (p <0.05) reduced by nifedipine (10-6 
M) or EDTA (10-3 M) (Figure 11): IC50 values (95% C.L.) for the B. diffusa 
methanolic root extract in the presence of nifedipine or EDTA were 315 (204- 
488) µg/ml and 228 (179-290) µg/ml, respectively. In contrast, cyclopiazonic 
acid (10-5M) significantly increased the inhibitory response induced by the B. 
diffusa root extract with IC50 value (95% C.L.)of 5.44 (3.95-7.49) µg/ml 
(Figure 11). The effect of nifedipine, a Ca2+ channel blocker of L-type and 
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EDTA, a calcium chelator, on the inhibitory effect of the B. diffusa methanolic 
root extract on the ACh-induced contractions suggest an involvement of 
extracellular calcium and/or L-type calcium channels. 
Conversely, cyclopiazonic acid, a potent and specific inhibitor of the 
sarcoplasmatic reticulum Ca2+-ATPase in smooth muscle (i) reduced the 
inhibitory effect of the metanolic root extract of B. diffusa on the ACh-induced 
contractions and (ii) produced a leftward shift of the inhibitory curve (Figure 
11).  
The methanolic root extract of B. diffusa was then subjected to the modified 
Kupchan partition scheme from which four fractions were obtained (n-hexane, 
CCl4, CHCl3, and  n-BuOH fractions). The obtained extracts were subjected to  
the preliminary evaluation of their effect on intestinal motility. This test 
revealed the maximum spasmolytic activity for the CCl4 and CHCl3 extracts, 
while the remaining two fractions were inactive (Figure 12).  
In order to get more information on the smooth muscle contraction 
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Figure 11. Acetylcholine-induced contractions in isolated guinea pig 
ileum: effect of the methanolic root extract of Boerhaavia diffusa (1-
1000 µg/ml) alone or in the presence of nifedipine (10-6 M), 
cyclopiazonic acid (10-5 M)  and EDTA (10-3 M). Each point represents 
the mean ± SEM of 6-8 experiments. **p < 0.01; ***p < 0.001 vs 
vehicle. 
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Figure 12. Effects of cloroformic (CHCl3) tetracloruric (CCl4), n-hexane 
and butanolic (BuOH) fractions obtained from the methanolic root extract 
of B. diffusa (1-1000µg/ml) on contractions on isolated guinea pig ileum 
induced by acetylcholine (Ach, 10-6 M). Each point represents the mean ± 
SEM of 6-8 experiments. 
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inhibitory activity of the nonprenylated rotenoids contained in the B. diffusa 
root, the methanolic root extract of this plant was carefully examined and the 
twelve rotenoid derivatives (1-12) were isolated, three of which are new 
compounds (4, 5 and 12) (Figure 13). 
The evaluation of the spasmolytic effect of the twelve isolated rotenoids (1-
12) showed that the compounds 2, 3 and 5, but not the compounds 1 and 4, 
were able to reduce the acetylcholine-induced contractions with the following 
IC50 value (95% C.L.): 11.0 (10.2 – 12.3) µg/ml for boeravinone E (2), 4.22 
(2.16 – 8.21) µg/ml for boeravinone G (5) and 5.46 (4.45 – 6.69) µg/ml for the 
compound 3. In addition, the compounds 2 and 3, at the concentration of 30 
µg/ml, produced a complete inhibition of the acetylcholine-induced 
contractions, while the maximal inhibition achieved by boeravinone G (5) at 
the concentration of 30 µg/ml was 60 % (Table 1). The compounds 7-10 and 
12 reduced the acetylcholine-induced contractions (at 30 µg/ml). By contrast, 
the compounds 6 and 11 were completely inactive. None of these compounds 
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Figure 13. Rotenoids isolated from the methanolic root extract of Boerhaavia 
diffusa and tested on intestinal motility. 
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 (6-12) inhibited the acetylcholine-induced contractions completely: indeed, 
the maximal inhibition (Emax) achieved for each of the compounds 7-10 and 12, 
at the tested concentrations, was about 20-50% (Table 1). Papaverine, used as 
a reference drug, reduced the acetylcholine-induced contractions with a 
percentage of maximum inhibition of 72.3 ± 7.6 at the concentration of 30 
µg/ml (Table 1). 
4.2 Antioxidant Activity 
4.2.1 Electron Spin Resonance Spectroscopy (ESR) 
The methanolic root extract of B. diffusa (5 mg/ml) induced a significant 
peak height reduction of the absorbance (B signal) in relation to the control 
peak height (A signal) (Figure 14). The variation of the absorption of the peak 
height presents the measure of the antiradical activity. As shown in Figure 14, 
the reaction of Fe2+ with H2O2 in the presence of the spin trapping agent 
DMPO, generated a 1:2:2:1 quartet of lines in the ESR spectra with the 
hyperfine coupling parameters (aN and aH=14.9 G). 
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Table 1. Inhibition of ACh-induced contractions by rotenoids  
1-12 at 30 µg/ml.  
 
Rotenoids Emaxa 
boeravinone D (1) 
boeravinone E (2) 
compound 3 
boeravinone G (4) 
boeravinone H (5) 
boeravinone C (6) 
compound 7 
coccineone E (8) 
isoflavone 9 
boeravinone F (10) 
coccineone B (11) 
compound 12 
papaverine 
Inactiveb 
100 
100 
60.0± 6.9 
Inactiveb 
Inactive 
19.4 ± 1.3 
25.2 ± 2.0 
36.8 ± 3.2 
50.0 ± 8.2 
Inactiveb 
36.1 ± 3.3 
72.3±7.6 
  
a Emax indicates the percentage of maximum inhibition. 
b Inactive means with no effect on ACh-induced contractions. 
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Figure 14. Representative ESR spectra of DMPO-
OH spin adduct signal (A) and DMPO-OH spin 
adduct signal in the presence of 5 mg/ml of 
Boerhaavia diffusa methanolic root extract (B).  
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The methanolic root extract of B. diffusa  (0.1-5 mg/ml) produced a 
concentration-dependent inhibition of the ESR signal intensity of the DMPO-
OH spin adduct with the IC50 of 0.7 mg/ml (Table 2).   
The CCl4 and the n-BuOH fractions, among the four ones (n-hexane, CCl4, 
CHCl3, n-BuOH) obtained by a modified Kupchan procedure, were able to 
reduce the ESR signal intensity, where the former was more active (Table 3). 
The carbon tetrachloride extract produced a total elimination of hydroxyl 
radical (AA = 100%) at the concentration of 0.7 mg/ml.  
The chromatographic purification of the CCl4 fraction through column 
chromatography on a silica gel led to the formation of 13 sub-fractions whose 
antioxidant activity was evaluated by ESR assay (Table 4).  
The HPLC purification of the most active sub-fractions (BOE 4, BOE 6, 
BOE 8 and BOE 9) led to the isolation of boeravinone G, boeravinone H and 
boeravinone D (structures in Figure 13) which, at the concentration of 0.5 
mg/ml, showed a scavenger activity of  65.9±3.3 %, 50.2±2.4 % and  
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Table 2: Antioxidant activity of the methanolic root extract of 
Boerhaavia diffusa (0.1-5 mg/ml) detected by ESR assay, expressed 
as percentage of the reduction of peak height of the absorbance. 
Each value represents  the mean ± SEM of 6 experiments.  **p<0.01 
e ***p<0.001.  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
Boerhaavia  diffusa (mg/ml) %AA 
0.1  
0.5  
1.0 
3.0 
5.0 
12.2 ± 0.51 
 26.55 ± 0.62 
    52.32 ± 0.98** 
    66.9 ± 0.57*** 
      71.22 ± 0.43*** 
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Table 3: Antioxidant activity, detected by ESR assay, of the fractions obtained from 
Kupchan partitioning of the methanolic root extract of Boerhaavia diffusa expressed as 
percentage of peak height of the absorbance. 
 
Fraction 0.1 mg/ml 0.5 mg/ml 1 mg/ml 3 mg/ml 5 mg/ml 
 Hexane 
Cloroformic 
Tetracloruric 
Butanolic 
0 
0 
59.9±0.87 
15.5±0.54 
0 
0 
85.5±0.84 
35.6±0.73 
0 
0 
100 
61.2±0.89 
0 
0 
100 
68.9±0.91 
0 
0 
100 
78.1±0.41 
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Table 4: Antioxidant activity of the fractions obtained from the carbon 
tetrachloride extract of Boerhaavia diffusa root detected by ESR assay 
 
Sub fractions AA (%) 
0.01 mg/ml 0.15 mg/ml 1.00 mg/ml  
BOE 1 
BOE 2 
BOE 3 
BOE 4 
BOE 5 
BOE 6 
BOE 7 
BOE 8 
BOE 9 
 BOE 10 
 BOE 11 
 BOE 12 
 BOE 13 
26.32 
24.41 
23.22 
31.24 
20.13 
30.12 
24.13 
33.34 
32.98 
0 
22.32 
15.12 
20.12 
76.87 
78.05 
77.45 
82.93 
65.85 
81.71 
75.61 
82.32 
81.71 
12.19 
75.61 
51.22 
75.61 
91.50 
92.20 
88.45 
98.75 
82.31 
100 
86.71 
100 
100 
51.25 
90.81 
75.25 
88.45 
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48.6±1.4 %, respectively. 
Boeravinone G (1,0 mg/ml), isolated from the BOE 4 fraction, showed the 
antiradical activity (AA%) (expressed as a percentage of the peak height of the 
absorbance) of the 95.9±4.6 %.  
4.2.2 Sucrase- Isomaltase Activity  
In order to evaluate the differentation grade of the Caco-2 cells a time 
course of the sucrase-isomaltase enzymatic activity was performed. The 
sucrase-isomaltase activity increased in a time-dependent manner until the day 
12 (Figure 15).  
4.2.3 TBARS Assay 
Lipid peroxidation is considered as the major mechanism of cellular injury 
in many biological systems of plant and animal origin. The mechanism 
involves the process whereby the unsaturated lipids are oxidized to form the 
additional radical species as well as toxic by-products that can be harmful to 
the host system. In this study, the lipid peroxidation was determined by 
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Figure 15. Time course of sucrase-isomaltase activity. Each value represents the mean 
± SEM of 4 experiments. 
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measuring TBARS. The treatment of the Caco-2 cells with H2O2/Fe2+ (1 mM) 
produced a significant (p<0.001) threefold increase in TBARS formation 
(Figures 16 and 17). The pre-treatment of the Caco-2 cells with the methanolic 
root extract of B. diffusa (30-300 µg/ml) reduced the H2O2/Fe2+-induced 
TBARS formation significantly (p<0.01- 0.001) in a concentration-related 
manner (Figure 16). The effect was significant starting from the concentration 
of 30 µg/ml. Similarly, boeravinone G (0.0001-0.001 µg/ml) was able to 
reduce the levels of TBARS significantly (p<0.001) and in a concentration 
dependent manner (Figure 17). 
4.2.4 Intracellular ROS Measurement  
The oxidative stress is a condition associated with an increased rate of the 
cellular damage induced by oxygen and oxygen-derived oxidants called 
reactive oxygen species (ROS). The exposure of the Caco-2 cells to H2O2/Fe2+ 
(2mM) produced a significant (p<0.05-0.001) increase in the ROS formation 
(Figures 18 and 19). The pre-treatment for 24 hrs with the methanolic  
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Figure 16. Effect of the methanolic root extract of Boerhaavia diffusa 
(30-300 µg/ml) on Fenton reagent (H2O2/Fe2+ 1 mM)-induced 
malondialdehyde (MDA) production after 24 hrs of exposure in 
differentiated Caco-2 cells. Data represent mean ± S.E.M of 6 
experiments. #p<0.001 vs control; **p<0.01 and ***p<0.001 vs 
H2O2/Fe2+ alone. 
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Figure 17. Effect of boeravinone G (0.0001-0.001 µg/ml) on 
Fenton reagent (H2O2/Fe2+ 1mM)-induced malondialdehyde 
(MDA) production after 24 hrs of exposure in differentiated 
Caco-2 cells. Data represent mean ± S.E.M of 6 experiments. 
#p<0.001 vs control; ***p<0.001 vs H2O2/Fe+2 alone. 
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root extract of B. diffusa  (30-300 µg/ml) or boeravinone G (0.0001-0.001 
µg/ml) reduced significantly (p<0.05-0.001) and in a concentration dependent 
manner the ROS formation as measured by the inhibition of DCF fluorescence 
intensity (Figures 18 and 19). 
4.3 Genoprotective Activity (Comet Assay) 
The treatment of the Caco-2 cells with H2O2  75 µM induced the double 
helix DNA breakage of the Caco-2 cells. The DNA fluorescence tail of the 
H2O2-damaged Caco-2 cells was about 43%, while the control was about 5%. 
A pre-treatment with the methanolic root extract of B. diffusa (30-300 µg/ml) 
reduced the DNA damage significantly (p<0.01-0.001) and in a concentration 
dependent manner (Figure 20). Consistent with the TBARS assay, a significant 
inhibitory effect was achieved for the 30-300 µg/ml concentrations. Figure 21 
shows an example of the Caco-2 cells exposed to 75 µg/ml H2O2 or H2O2 plus 
the methanolic root extract of B. diffusa. 
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Figure 18. Effect of the methanolic root extract of Boerhaavia 
diffusa (30-300 µg/ml) on Fenton reagent (H2O2/Fe2+ 2 mM)-
induced reactive species reagents (ROS) production after 24-hrs 
exposure in differentiated Caco-2 cells. Data represent mean ± 
S.E.M of 6 experiments. #p<0.001 vs control; *p<0.05 and 
***p<0.001 vs H2O2/Fe+2 alone 
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Figure 19. Effect of boeravinone G (0.0001-0.001 µg/ml) on 
Fenton reagent (H2O2/Fe2+ 2 mM)-induced reactive species 
reagents (ROS) production after 24-hrs exposure in differentiated 
Caco-2 cells. Data represent mean ± S.E.M of 6 experiments. 
#p<0.01 vs control; *p<0.05, **p<0.01 and  ***p<0.001 vs 
H2O2/Fe+2 alone. 
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Figure 20. DNA damage (tail intensity) detected by the Comet 
assay in Caco-2 cell line exposed to 75 µM H2O2 for 5 min. in 
absence or presence of the methanolic root extract of Boerhaavia 
diffusa (30-300 µg/ml). Data represent mean ± S.E.M of 4 
experiments. #p<0.001 vs control; **p<0.01 and ***p<0.001 vs 
H2O2 alone. 
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Figure 21.Examples of Comet images showing different levels of DNA damage 
in Caco-2 cells.  
(a)  Comet showing 50 % of the DNA damage induced by H2O2 75 µM 
(b)  Comet showing 30 % of the DNA damage induced by H2O2 75 µM after 
24-hrs pre-treatment with the methanol root extract of Boerhaavia diffusa (300 
µg/ml)  
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4.4 BCRP Mediated Inhibition Assay 
 
  
 The rotenoids isolated from B. diffusa were assayed for the inhibition of 
the BCRP activity by flow cytometry on HEK- 293 human cells transfected by 
wild-type (R482) BCRP and exposed to the antitumor drug mitoxantrone 
(Ahmed-Belkacem et al., 2005). Table 5 shows the efficiency of boeravinone 
G, boeravinone H, boeravinone E, boeravinone B, boeravinone C, coccineone 
B, boeravinone A, coccineone E, 6-O-dimethylboeravinone H, boeravinone I 
and boeravinone J to inhibit BCRP-mediated mitoxantrone efflux, leading to 
the drug accumulation (Figure 9). Boeravinone G and boeravinone H induced 
a high accumulation of mitoxantrone at the lowest concentration tested, 
through a strong inhibition of the BCRP drug-efflux activity (Figure 22). For 
boeravinone G, nearly the complete effect was achieved that is produced by 
elacridar (GF120918), a commonly used BCRP inhibitor, taken here as a 
reference substance. A concentration dependent study enabled the 
determination of IC50 values of 0.7 ± 0.07 µM for boeravinone G and 2.5 ±  
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Figure 22. Concentration-dependent inhibition by boeravinone G and boeravinone H of 
BCRP-mediated mitoxantrone efflux. BCRP-transfected HEK- 293 cells were 
incubated as in Table 5 in the presence of increasing concentrations of either 
boeravinone G (panel A) or boeravinone H (panel B). The data obtained from three 
separate experiments are indicated as the mean ± SD. The IC50 was determined 
graphically as the concentration producing half-maximal mitoxantrone accumulation. 
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0.47 µM for boeravinone H, respectively. Most of the remaining boeravinones 
(boeravinone A, boeravinone B, boeravinone E, coccineone B and boeravinone 
C) were less active and required the higher concentrations to produce 
appreciable inhibition, while 6-O-dimethylboeravinone H and the new 
boeravinone I and boeravinone J displayed only a marginal inhibitory activity 
(Table 5). 
4. 5 Toxicological Studies 
4.5.1 Cytotoxicity Assay  
4.5.1.1 MTT Assay 
 The results regarding the citotoxicity assay on the methanolic root extract 
of B. diffusa and on boeravinone G, performed on the Caco-2 cells are shown 
on the Figure 23 and Figure 24. The exposure of the differentiated Caco-2 cells 
to the various concentrations of the methanolic root extract of B. diffusa 1-300 
µg/ml (Figure 23) and to the most antioxidant rotenoid boeravinone G
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Table 5. Efficacy of rotenoids to inhibit BCRP-mediated mitoxantrone efflux leading to the drug accumulation 
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Sostituents 
Compounds 3 4 6 8 9 10 6a/12a Concentration used 
(µM) 
% maximal mitoxantrone 
 accumulation 
boeravinone G  H OH OMe H OMe H DBC 5 92 ± 6.5 
boeravinone H H OH OMe H OMe Me DB 5 68 ± 6.1 
boeravinone E  OH H OH H OH Me DB 10 56 ± 5.0 
boeravinone B  H H OH H OH Me DB 10 55 ± 5.8 
boeravinone C  H OH H H OMe Me 12a-OH 10 31 ± 4.2 
coccineone B  H H OH H OH H Db 10 29 ± 5.3 
boeravinone A  H H OMe H OH Me Db 10 27 ± 5.1 
coccineone E  H H H H OMe OMe 12a-OH 10 15 ± 5.2 
6-O-dimethylboeravinoneH H OH OH H OMe Me DB 20 15 ± 3.1 
boeravinone I  H H OH OH OMe Me DB 20 12 ± 5.4 
boeravinone J  OH H B ring with 5 atoms H OH Me DB 20 15 ± 3.1 
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Figure 23. Effect of the methanolic root extract of Boerhaavia diffusa (1-300 
µg/ml) on the differentiated the Caco-2 cells. Data represent mean ± S.E.M of 8 
experiments  
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Figure 24. The exposure of the differentiated Caco-2 cells to the 
various concentrations of the most antioxidant rotenoid 
boeravinone G (0.0001-0.001 µg/ml). Data represent mean ± 
S.E.M of 6 experiments. 
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 (0.0001-0.001 µg/ml corresponding to 0.28-2.8 µM) (Figure 24) resulted in no 
effect on the cell survival.  
4.4.1.2 Lactate Dehydrogenase (LDH) Leakage Assay 
In accordance with the results of the MTT assay, the methanol root extract 
of Boerhaavia diffusa (1-300 µg/ml) (Figure 25) and boeravinone G (0.0001-
0.001 µg/ml) (Figure 26) did not produce an increase in the release of LDH 
from the Caco-2 cell line.  
 4.4.2 Genotoxicity Assay (Comet Assay) 
The Comet assay is used not only to determinate the capacity of a drug to 
protect the DNA from insults, but it is also used to evaluate the genotoxicity of 
a drug. In our study, the methanolic root extract of B. diffusa, at the 
concentrations ranging from 30 to 300 µg/ml, did not produce the DNA 
damage detected by the Comet assay in the Caco-2 cells. Thus, this result 
escluded a genotoxic activity of the B. diffusa methanolic root extract (Figure 
27). 
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Figure 25. Exposure of the differentiated Caco-2 cells to the various 
concentrations of the methanolic root extract of Boerhaavia diffusa  
(1-300 µg/ml). Data represent mean ± S.E.M of 6 experiments. 
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Figure 26. Exposure of the differentiated Caco-2 cells to the various 
concentrations of the most antioxidant rotenoid boeravinone G 
(0.0001-0.001 µg/ml). Data represent mean ± S.E.M of 6 
experiments. 
 
 
 
 
 
 92
 
 
 
 
 
 
0 30 100 300
0
2
4
6
8
Boerhaavia diffusa [µg/ml]
Ta
il 
in
te
ns
ity
 (%
)
 
Figure 27. DNA damage (tail intensity) detected by the Comet 
assay in Caco-2 cell line exposed to the methanolic root extract of 
Boerhaavia diffusa (30-300 µg/ml). Data represent mean ± S.E.M 
of 4 experiments.  
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5.0 DISCUSSION 
Boerhaavia diffusa is one of the most popular herbal remedies in the Indian 
Ayurvedic medicine that prescribes roots of Punarnava as diuretic, expectorant, 
vermifuge, analgesic and to improve the functions of kidney and liver (Lad, 
1999). B. diffusa is also widely used in Ayurvedic medicine for the treatment of 
various gastro-intestinal disorders such as diarrhoea and abdominal pain. 
However, despite its wide use, there were not carried out experimental and 
clinical studies that confirm its effectiveness. 
Spasmolytic Activity 
Gastrointestinal diseases are acute and severe public health problems all 
over the world. It has been assessed, for example, that 1.4 million people in the 
United States and 2.2 million people in Europe suffer from diarrhoea, 
constipation or abdominal pain (Loftus, 2004).  
In the present study, we tried to investigate the effect of a methanolic root 
extract of B. diffusa on intestinal motility. In particular, we evaluated the effect 
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of B. diffusa root extract on the contractions induced either by exogenous 
spasmogens (acetylcholine, histamine or barium chloride) or by electrical field 
stimulation (EFS) of the isolated guinea-pig ileum.  
Our results showed that a methanolic extract obtained from the root of  B. 
diffusa exhibited a concentration-dependent inhibition of both exogenous 
spasmogens (i.e., acetylcholine, histamine, and barium chloride) and EFS-
evoked contractions in the isolated guinea pig ileum. Acetylcholine, histamine, 
BaCl2 and EFS induced the ileum contraction by different mechanisms: 
acetylcholine and histamine act through the activation of postjunctional 
receptors while EFS acts through the release of acetylcholine from enteric 
nerves; BaCl2 through a postjunctional non-receptor-mediated mechanism. 
Since no significant difference was observed in the B. diffusa inhibition curves, 
the spasmolytic effect of B. diffusa is probably due to a direct effect on smooth 
muscle. It is very unlikely that the antispasmodic effect of the methanolic root 
extract of B. diffusa is due to antimuscarinic action (atropine-like), since this 
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herbal drug also inhibited the contractions induced either by BaCl2 (which does 
not act through a receptor-mediated mechanism) or histamine (which acts on H1 
receptors).  
Since the inhibitory effect of the methanolic root extract of B. diffusa was 
exerted at post-junctional level, we investigated the mechanism of the 
antispasmodic activity of this herbal extract on the contractions induced by 
acetylcholine.              
The contractions of all smooth muscles, including those of gastrointestinal 
tract, absolutely depend on the presence of calcium (Ca2+). Agonists-induced 
contractions may be related to the release of intracellular Ca2+ from the 
sarcoplasmic stores in addition to the influx of extracellular Ca2+, mainly 
through the L-type Ca2+ channels (Makhlouf, 1994). Consequently, smooth 
muscle contraction can be abolished by antispasmodic drugs through the 
inhibition of Ca2+ entry or release into the cells. In the present study, we have 
shown that nifedipine, a blocker of the L-type Ca2+ channels and EDTA, a 
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calcium chelator,  reduced the inhibitory effect of the methanolic root extract of 
B. diffusa on acetylcholine-induced contractions suggesting an involvement of 
L-type channels. Cyclopiazonic acid, a potent and specific inhibitor of the 
sarcoplasmatic reticulum Ca2+-ATPase in smooth muscle (Grasa et al., 2004), 
did not reduce the inhibitory effect of the methanolic root extract of B. diffusa 
on ACh-induced contractions, but instead produced a leftward shift of the 
inhibitory curve. This action excludes an involvement of the release of Ca2+ 
from sarcoplasmic stores in the inhibitory action of  the methanolic root extract 
of B. diffusa. 
In order to distinguish the responsible metabolites of the spasmolytic 
activity of B.diffusa methanol root extract, the extract was fractioned following 
the modified Kupchan method (Kupchan et al.,1973) in five fractions: hexane, 
tetrachloruric, chloroformic, butanolic and aqueous fractions. These fractions 
were subjected to preliminary evaluation of their effect on intestinal motility. 
This test revealed a maximum spasmolytic activity for CCl4 and CHCl3 
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fractions, while the remaining three fractions were inactive. Through a 
bioassay-guided separation, twelve compounds belonging to the rotenoids class 
(Figure 7) were isolated, three of them isolated for the first time and named 
boeravinone G (5), boeravinone H (4) and 6,10,11-trihydroxy-9-
methoxyrotenone (12). 
Pharmacological tests showed that only boeravinone E (2, 100 % of 
inhibition), boeravinone G (5, 60 % of inhibition) and 6-O-
demethylboeravinone H (3, 100 % of inhibition) exibited a high spasmolytic 
activity, the compounds 7-10 and 12 reduced acetylcholine-induced 
contractions (at 30 µg/ml) at about 30%, while, in contrast, boeravinone H (4), 
boeravinone C (6) and coccineone B (11) were completely inactive. 
The evaluation of the spasmolytic activity within the series of rotenoids 
isolated from the methanolic root extract of B. diffusa during the present study 
allowed to get a complete formulation of structure-activity-relationship, in 
particular to estimate the effect of substitutions at the two aromatic rings and of 
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O-methylation at C-6 on the spasmolytic activity. In particular, the comparison 
of the activities of boeravinone D (1) with boeravinone E (2) and those of 
boeravinone H (4) with 6-O-demethylboeravinone H (3) clearly suggested that 
O-methylation at position 6 was deleterious for the pharmacological activity (at 
30 µg/ml, only boeravinone E (2) and 6-O-demethylboeravinone H (3)  
produced a complete inhibition of ACh-induced contractions while the maximal 
inhibition achieved by boeravinone G (5) at the concentration of 30 µg/ml was 
60 %. On the other hand, the same methylation seemed to be better tolerated 
when a methyl was lacking on the ring D (it is the case of boeravinone G (5)), 
which retained a good activity. Finally, comparison of the activities of 
boeravinone E (2)  and 6-O-demethylboeravinone H (3) suggested that the 
linkage position of the OH group on ring A was not critical. 
The activities of compounds 6-10 clearly highlighted the crucial role of the 
ring B (see Table 1). Indeed, the compounds 6-8, showing hydration of the 
double bond, ∆6a(12a), irregardless of the presence of either a H, a CH3, or an 
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OCH3 at C-10, showed a reduced activity or no activity. By analogy, the 
isoflavone 9, characterized by an opened ring B, possessed a low activity. On 
the other hand, the oxidation of the hemiacetal group at C-6 to a lactone group 
(as in compound 10) appeared to be better tolerated; however, the activity of 
boeravinone F (10) was markedly lower compared to its reduced analogue, 
boeravinone E (2), which appeared to be the most potent rotenoid tested. 
Finally, the low potencies of the compounds 11 and 12 indicated that the 
presence of a hydroxylated pyran ring B is not sufficient for the exhibition of 
spasmolyitic activity. Most likely, a monohydroxylated ring A and/or a 
trisubstituted ring D are also needed.  
The data presented herein strengthen the observation that non-prenylated 
rotenoids are responsible for the smooth muscle relaxant activity of the 
investigated B. diffusa methanolic root extract. It should be noted that an action 
on intestinal motility has not been reported previously for this class of 
molecule. On the other hand, the structurally comparable stilbenoids to some 
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extent from Nidema boothii, have been reported recently to show a spasmolytic 
activity (Hernandez-Romero et al., 2004). Interestingly, structure-activity 
relationships established for stilbenoids (hydroxylation of both phenyl rings is 
needed, while methylation of hydroxyl groups is detrimental) resemble those 
proposed herein for non-prenylated rotenoids.  
In conclusion, the present results demonstrate that the methanolic root 
extract of B. diffusa directly inhibits the intestinal motility with a mechanism 
involving the L-type Ca2+ channels. Moreover, this action seems due to the 
presence of rotenoids. These results could explain, at least in part, the clinical 
efficacy of this Ayurvedic remedy in the treatment of gastrointestinal disorders.  
Antioxidant Activity 
There is a growing evidence that oxygen-derived free radicals play an 
important role in the pathogenesis of the gastrointestinal disorders. Free 
radicals are highly reactive species that can induce molecular alterations that 
involve changes in the morphology and cell viability: these changes include 
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damage of DNA and the oxidation of protein cross-bonds and its lateral chains. 
Free radicals (reactive oxygen species, ROS) are products of "wastes" that are 
formed naturally in the cells when oxygen is used in metabolic processes to 
produce energy (oxidation). The lipid peroxidation, for example, is one of the 
main factors responsible for the functional and structural alterations of the cell 
membrane caused by oxidative stress (Ames et al., 1993; Cotelle et al., 1996; 
Halliwell et al., 2000; Brand-Williams et al., 2001). The cells are naturally 
provided with a large number of protective antioxidant systems, enzyme and 
non-enzymatic (such as superoxide dismutase-SOD, catalase, etc.) contrasting 
these potentially harmful oxidizing agents. This multifunctional protective 
system, however, does not entirely counteract the deleterious effects of ROS 
and consequently damaged molecules from oxidative phenomena accumulate in 
cells. The clinical implications of these changes can be serious, in fact, the 
accumulation of ROS in many cellular components is known to be the main 
cause of damage of molecules that leads to cell aging and related diseases, such 
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as cancer and decline of the immune system (Milić et al., 2000). One of the 
systems to prevent cellular damage mediated by the ROS is to increase the 
body defences through exogenous antioxidants (Fahey et al., 1997). 
Consistently, antioxidant compounds are believed to prevent a number of 
gastrointestinal diseases (Janne et al., 2000; Gatof et al., 2002; Piquet et al., 
2006) and drugs with antioxidant activity are currently used in the treatment of 
gastrointestinal cancer (Trueba et al., 2004; Oz et al., 2005; Dryden et al., 
2006). Since B. diffusa, is a medicinal plant widely used in Ayuervedic 
medicine for the treatment gastrointestinal disorders, in the present thesis we 
evaluated if this medicinal plant possesses antioxidant properties.  
One of the approaches to assess the antioxidant activity is to examine free 
radical production directly and its inhibition by using highly sensitive Electron 
Spin Resonance (ESR) spectroscopy. The ESR is an analytical assay 
(discovered and applied for the first time by Zavoiskj in 1944) that measures 
the presence, structure, dynamics and concentration of free radicals directly 
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(Calliste et al., 2001). Applying this method it is possible to evaluate the effect 
of the drug on the formation of radical species obtained by the Fenton reaction 
which provides for the use of hydrogen peroxide (H2O2) and ferrous sulphate 
(FeSO4) as oxidizing agents. 
Since the hydroxyl radicals are very unstable, it is necessary to use an 
exogenous spin trap [5,5-dimethyl-1-pyrroline-N-oxide (DMPO)] that reacts 
with the free radical species thus generating more stable adducts (increasing 
their “half life”) with the characteristic ESR profiles. Using the ESR assay in 
the present thesis, it has been found that the methanolic root extract of B. 
diffusa (reducing the signal intensity of ESR) possesses a scavenging activity.  
Using the Caco-2 cell line and H2O2 as a free radical generator, the 
antioxidant effect of the methanolic root extract of B. diffusa was further 
investigated by evaluating the MDA and the ROS production.  
  Lipid peroxidation is a complex process that can occur in biological 
membranes that are made up of molecular oxygen-reactant polyunsaturated 
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fatty acids, leading to the production of lipid hydroperoxides and their 
metabolites. The lipid peroxidation can occur in various pathological conditions 
including atherosclerosis, rheumatoid arthritis, angina, cancer and irritable 
bowel diseases (IBD). 
A simple and largely used method involves thiobarbituric acid-reactive 
substances which are highly used as lipid peroxidation markers (eg. like 
malondialdehyde) (Janero, 1990). Hence, malondialdehyde (MDA) is a quite 
adequate indicator of lipid peroxidation caused by free radicals. Using this 
assay, various Authors have discovered the antioxidant activity of the B. diffusa 
extract obtained from a different part of this Ayurvedic plant (i.e. from the 
leaves and not from the root) in liver and kidney of alloxan-induced diabetic 
rats (Satheesh et al., 2004). In the present thesis, not only was it reported for the 
first time the antioxidant activity of the methanolic root extract of B. diffusa in 
the intestinal cells using the TBARS assay, but the antioxidant activity is also 
confirmed using a more specific assay, namely Reactive Oxygen Species 
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(ROS) formation assay induced by H2O2 using a fluorescent approach. Indeed, 
although sensitive, the MDA assay is not specific since, many other biological 
species can react with TBA (Esterbauer and Cheeseman,1990). In fact, ROS are 
essential intermediates in oxidative metabolism. Nonetheless, when generated 
in excess, ROS can damage cells by peroxidizing lipids and disrupting 
structural proteins, enzymes and nucleic acids. Excess of ROS is generated 
during various cell stresses, including ischemia/reperfusion, exposure to 
ionizing and ultraviolet radiation and/or inflammation. 
A great number of in vitro experiments have showed that ROS damage 
DNA, which appears to represent the major target involved in mutagenesis, 
carcinogenesis and aging cell responses (Nakabeppu et al., 2006; Karihtala and 
Soini, 2007). The deleterious effects of ROS are counteracted by several 
mechanisms permitting an efficient antioxidant defence. The antioxidant 
capacity neutralizes the ROS production under the physiological conditions, but 
when an excess of ROS is generated (ETC dysfunction, ischemia/reperfusion, 
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apoptotic process, etc.) or if the antioxidant defence system is afflicted 
(malnutrition, genetic disease, neurodegenerative disease, etc.), an oxidative 
stress is created corresponding to the detrimental effect of ROS. Therefore, it 
has also been decided to evaluate the potential protective effect of the methanol 
root extract of B. diffusa on the ROS-induced DNA damage. The DNA damage, 
induced by using H2O2, which is a well-known genotoxic agent able to induce 
the oxidative DNA damage, was evaluated by the Comet assay, which is a very 
sensitive method widely used to evaluate the genotoxic/genoprotective effects 
of drugs. The damage is represented by an increase of the DNA fragments 
(generated by DNA double strand breaks, single strand breaks and/or strand 
breaks induced) that have migrated out of the cell nucleus in the form of a 
characteristic streak similar to the tail of a comet. The length and fragment 
content of the tail is directly proportional to the amount of DNA damage (Loft 
et al., 1996; Stenkellner et al., 2001; Verhagen et al., 1997; Verhoenven et al., 
1997; Collins, 2004). Our experiments suggest that the protective action of the 
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methanolic root extract of  B. diffusa, assessed by TBARS and ROS assays (see 
above), is closely related to reduction of the DNA damage induced by H2O2. 
Indeed, the methanolic root extract of  B. diffusa was able to reduce H2O2-
induced DNA damage significantly at the concentration of 30-300 µg/ml .  
 In order to detect the chemical components of the methanolic root 
extract of B. diffusa responsible for the antioxidant activity, this extract was 
partitioned to obtain four extracts (namely n-hexane, CCl4, CHCl3, n-BuOH). 
An ESR-guided fractionation of the most antioxidant extract (CCl4) led to the 
isolation of three rotenoids, boeravinone D, G and H with a remarkable radical 
scavenging activity. Obtained results identified rotenoids as the active 
antioxidant components of the methanolic root extract of B. diffusa.  
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Figure 28. Boeravinone G, boeravinone H and boeravinone D 
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Since our previous investigations revealed that the rotenoid mixture of B. 
diffusa was made up of at least sixteen molecules (Ahmed-Belkacem, et al., 
2005; Borrelli et al., 2005), it was surprising to notice that only boeravinones 
D, G, and H seemed to play a major role in the antioxidant activity of the 
extract. The chemical structures of these compounds are reported in Figure 28. 
The common features of boeravinone G, boeravinone D and boeravinone H ( 
Figure 28) are a planar ring C, the presence of free hydroxyl groups on the ring 
A at the position 11 and the presence of a methoxy group at the position 6. 
Remarkably, in the pool of rotenoids present in methanolic root extract B. 
diffusa (Ahmed-Belkacem, et al., 2005; Borrelli et al., 2005), boeravinones D, 
G, and H are the only ones that possess, at the same time, all these features. 
From the results of this study, it is clear that the methanolic root extract  of 
B. diffusa possesses an antioxidant activity. This effect could be attributed to a 
donation of hydrogen, to an electron reduction and / or a direct scavenger 
activities. 
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Since boeravinone G exhibited a higher activity compared to boeravinone D 
and H, further experiments in this study were performed on this metabolite. The 
Caco-2 based assays (MDA and ROS formations) confirmed the antioxidant 
activity of  boeravinone G, and its likely major role in the antioxidant activity 
of the whole extract.  
BCPR Induced Inhibition 
Breast cancer resistant proteins (BCRP/ABCG2) has been a recently 
discovered multidrug transporter of cancer cells, belonging to the ABC (“ATP-
Binding Cassette”) superfamily of membrane proteins (Doyle, et al., 1998; 
Allikmets, et al., 1998; Miyake et al., 1999; Klein et al., 1999). It is 
overexpressed in many types of tumors, as acute myeloid  leukaemia, even 
before any chemotherapeutic treatment (Diestra et al., 2002). BCRP is able to 
efflux a wide spectrum of antitumor drugs, including mitoxantrone, 
camptothecin derivatives, methothrexate and anthracyclines, similarly to the 
first discovered and well characterized transporter P-glycoprotein (P-gp) 
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(Endicott and Ling, 1989). BCRPs as well as P-gp are largely expressed in 
human kidney and liver (Hilgendorf  et al., 2007). Considering the importance 
of several Ayurvedic herbal remedies in the treatment of hepatic and kidney 
deseases, as well as the relevance of B. diffusa itself in the adjuvant treatment, 
the effect of active rotenoids on the BCPR-inhibiting activity was also 
investigated in our experiments.  
Boeravinones G  and  boeravinone H  were resulted as the highly potent 
inhibitors of BCRP-mediated mitoxantrone efflux in the transfected HEK-293 
human cells. 
It was possible to establish structure-activity relationships toward the 
inhibition of BCPR-mediated drug transport activity, identifying the following 
substituent positive effects: (i) the absence of a methyl substituent at the  
position 10 in boeravinone G as compared to boeravinone H; (ii) the preference 
for a methoxy group over a hydroxyl group at the position 6 (boeravinone H 
versus 6-O-dimethylboeravinone H). It should be noted that when the position 
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4 was unsubstitued and a hydroxyl replaced the methoxy group at both 
positions 9 and 6, the two previous mentioned effects, (i) and (ii), appeared to 
be reversed (boeravinone B versus coccineone B and boeravinone B versus 
boeravinone A, respectively); (iii) an intact ring B, since its contraction to a 
five-membered ring giving a coumaronochromone derivative was clearly 
detrimental (boeravinone E versus boeravinone J). In contrast, a hydroxyl 
group at the position 3 appeared to be neutral (boeravinone E versus 
boeravinone B). Although the compounds boeravinone C and coccineone E had 
no direct counterpart, it seemed that loss of the double bond ∆6a(12a) between the 
rings B and C, and consequently, of the molecular planarity was deleterious for 
activity. Interestingly, a similar effect, at the same position, for 
flavanones/flavones was found (Corea et al., 2003). Analogically, the 
tetrasubstitution of the ring D, present in the compound boeravinone I, appears 
to be responsible for a marked decrease in activity. 
Toxicological Studies  
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Boeravinones belong to the chemical class of rotenoids, widely used as 
botanical insecticides and generally characterized by high toxicity (Gutman et 
al., 1970). Rotenoids are isoflavonoid derivatives typical secondary metabolites 
of Leguminosae and Fabaceae plants and, compared to tricyclic isoflavonoids, 
their peculiar structural features are: i) an additional oxygenated ring (ring B) 
almost invariable, ii) a 2,3-disubstitution on the ring A and iii) a prenyl group 
isoprenoid-derived group attached to the ring D usually at the position 8, 
commonly cyclized to form a five- or a six-membered ring (ring E) (Figure 29).  
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Figure 29. Left: General structure of rotenoids from Leguminosae and Fabaceae.  
  Right: General structure of rotenoids from Nyctaginalceae 
 
These compounds are frequently toxic through the inhibition of 
mitochondrial electron transport chain at the  complex I (Gutman et al., 1970). 
Because of these characteristics, in this thesis additional experiments were 
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carried out to prove that the methanolic root extract of B. diffusa and 
boeravinone G, at the concentrations used in the study, did not have any toxic 
effects. The cytotoxicity was assessed quantitatively by both MTT and LDH 
assays. No decrease was observed in the cell viability and no increase of LDH 
release when the cell lines were incubated in the presence of either the 
methanolic root extract of B. diffusa or boeravinone G. Moreover, the lack of 
toxicity of the methanolic root extract of B. diffusa was also demonstrated by 
the Comet assay, since the extract, administered alone (i.e. in absence of 
damage induced by H2O2) did not affect the DNA integrity.  
Collectively, these results suggest that the methanolic root extract of B. 
diffusa and boeravinone G are neither cytotoxic nor genotoxic in the Caco-2 
cells. Accordingly, in the existing literature, an interesting study is cited aiming 
at establishing the “toxophore” of rotenoid molecules, discovering that both the  
prenyl-derived ring attached at the ring D and a dimethoxy substitution on the 
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ring A are the essential requirements for their toxicity (Crombie  et al., 1992) 
(Figure 29). Fortunately, both these features are missing in B. diffusa rotenoids.  
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6.0 CONCLUDING REMARKS 
In conclusion, the results obtained in this thesis demonstrate that the 
methanolic root extract of B. diffusa possesses spasmolytic activities on 
intestinal smooth muscles. This effect seems to be due to the presence of 
boeravinones (which activity depend on their structure and clearly highlight 
the crucial role of ring B) and the involvement of extracellular calcium and/or 
L-type calcium channels Further, the methanolic root extract of B. diffusa 
also exerts antioxidant and genoprotective activity in both chemical and cell 
(intestinal Caco-2)-based assays. Boeravinone G, H and D appear to be the 
major responsible of the antioxidant activity, with boeravinone G playing a 
major role. In the light of the importance of antioxidant activity in the 
treatment or prevention of gut disorders and since our experiments were 
performed on isolated intestinal cells, it is suggested that the antioxidant 
activity here reported could explain, at least in part, the traditional use of this 
Ayurvedic remedy in treatment of gastrointestinal disorders. These 
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boeravinones, particularly boeravinone G, might be considered as lead 
compounds for the development of drugs potentially useful against those 
pathologies whose aetiology has been related to ROS-mediated injuries. The 
relatively simple chemical structure of boeravinones and the preliminary 
structure-antioxidant activity relationships presented here should be helpful 
in this task. 
Moreover, it has been shown that nonprenylated rotenoids isolated from 
Boerhaavia diffusa (boeravinones) could be identify as a new class of 
promising BCRP (ABCG2) inhibitors. The boeravinones (G and H in 
particular) as interesting BCPR inhibitors, are able to counter the 
phenomenon of drug resistance induced by anticancer drug. Hopefully, taking 
advantage of parallel information obtained for flavone derivatives, chemical 
modifications on their simple planar structures could pave the way for the 
development of even more potent MDR modulators.  
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Finally, the lack of cytotoxicity of these compounds makes them good 
candidates for in vivo tests as adjuvants in antitumor chemotherapy.  
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1H e 13C NMR data of 9-O-Methyl-10-hydroxycoccineone B (12).500 MHz, CD3OD. 
 
Pos. 12 12 
 δH, mult., J in Hz δC, mult. 
1 8.87, d, 7.8 126.5, d 
1a  116.6, s 
2 7.08, t, 7.8 122.2, d 
3 7.29, t, 7.8 128.3, d 
4 7.05, d, 7.8 116.2, d 
4a  147.7, s 
6 6.06, s 94.2, d 
6a  153.6, s 
7a  158.4, s 
8 6.30, s 97.3, d 
9  156.0, s 
9a 3.89, s, -OCH3 56.0, q 
10  132.2, s 
11  155.5, s 
11a  101.3, s 
12  179.2, s 
12a  109.1, s 
 
 
 
1H e 13C NMR data of boeravinone G (5).500 MHz, CD3OD. 
 
Pos. 5 5 
 δH, molt., J in Hz δC, molt. 
1 8.37, d, 7.5 119.5 (CH) 
1a  118.0 (C) 
2 7.09, t, 7.5 124.4 (CH) 
3 6.98, d,7.5 116.4 (CH) 
4  145.7 (C) 
4a  136.3 (C) 
6 5.84, s 96.6 (CH) 
6 3.61, s -O CH3 57.6 (CH3) 
6a  155.4 (C) 
7a  155.9 (C) 
8 6.45, s 94.2 (CH) 
9  167.0 (C) 
9a 3.89, s, -OCH3 56.9 (CH3) 
10 6.41, s 100.1 (C) 
11  163.8 (C) 
11 12.80, s -OH  
11a  107.7 (C) 
12  181.5 (C) 
12a  111.9 (C) 
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1H e 13C NMR data of boeravinone H (4).500 MHz, CD3OD. 
 
 
Pos. 4 4 
 δH, mult., J in Hz δC, mult. 
1 8.39, d 7.5 119.0 (CH) 
1a  117.6 (C) 
2 7.09, t 7.5 124.0 (CH) 
3 6.99, d 7.5 116.5 (CH) 
4  145.1 (C) 
4a  135.8 (C) 
6 5.90, s 96.6 (CH) 
6 3.61, s –OCH3 57.0 (CH3) 
6a  155.6 (C) 
7a  155.2 (C) 
8 6.46, s 90.1 (CH) 
9  164.3 (C) 
9 3.93, s  -OCH3 56.0 (CH3) 
10  110.5 (C) 
10 2.14, s – CH3 8.0 (CH3) 
11  159.9 (C) 
11 12.80, s -OH  
11a  106.5 (C) 
12  180.5 (C) 
12a  111.8 (C) 
 
 
1H e 13C NMR data of boeravinone I (15).500 MHz, CD3OD. 
 
Pos. 15 15 
 δH, mult., J in Hz δC, mult. 
1 8.75, d 7.5 126.8 (CH) 
1a  116.4 (C) 
2 7.02, t 7.5 122.4 (CH) 
3 7.19, d 7.5 128.0 (CH) 
4 6.97, d 7.5 115.8 (CH) 
4a  147.3 (C) 
6 6.12 s 95.4 (CH) 
6a  153.9 (C) 
7a  143.5 (C) 
8  123.9 (C) 
9  153.1 (C) 
9 3.80, s  -OCH3 56.2 (CH3) 
10  106.8 (C) 
10 2.01, s – CH3 10.1 (CH3) 
11  163.8 (C) 
11a  107.7 (C) 
12  179.0 (C) 
12a  110.0 (C) 
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1H e 13C NMR data of boeravinone J (16).500 MHz, CD3OD. 
 
Pos. 16 16 
 δH, mult., J in Hz δC, mult. 
1 7.81, d 7.0 121.2 (CH) 
1a  113.9 (C) 
2 6.93, d 7.0 113.9 (CH) 
3 7.19, d 7.5 158.9 (C) 
4 7.01, bs 99.3 (CH) 
4a  149.6 (C) 
6a  161.5 (C) 
7a  155.1 (C) 
8 6.48,s 94.1 (CH) 
9  164.5 (C) 
10 2.08, s – CH3 9.3 (CH3) 
10  108.3 (C) 
11  160.9 (C) 
11a  106.4 (C) 
12 8.75, d 7.5 178.2 (CH) 
12a  99.0 (C) 
 
 
 
